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Introduction Urokinase receptor (uPAR, CD87), a glycosylphos-
phatidylinositol-anchored protein, is considered to play an
important role in inflammation and fibrinolysis. The Gram-negative
bacterium  Burkholderia pseudomallei is able to survive and
replicate within leukocytes and causes melioidosis, an important
cause of pneumonia-derived community-acquired sepsis in South-
east Asia. We here investigated the expression and function of
uPAR both in patients with septic melioidosis and in a murine
model of experimental melioidosis.
Methods Using a translational approach we conducted a patient
study in patients with culture-confirmed sepsis caused by
B. pseudomallei,  in vitro experiments using wild-type (WT) and
uPAR knockout (KO) cells, and mouse studies using WT and
uPAR KO mice inoculated with B. pseudomallei.
Results  uPAR mRNA and surface expression was increased in
patients with septic melioidosis in/on both peripheral blood
monocytes and granulocytes as well as in the pulmonary
compartment during experimental pneumonia-derived melioidosis
in mice. uPAR-deficient mice intranasally infected with
B. pseudomallei showed an enhanced growth and dissemination
of B. pseudomallei when compared with WT mice, corresponding
with increased pulmonary and hepatic inflammation. uPAR KO
mice demonstrated significantly reduced neutrophil migration
towards the pulmonary compartment after inoculation with
B. pseudomallei. Further in vitro experiments showed that uPAR-
deficient macrophages and granulocytes display a markedly
impaired phagocytosis of B. pseudomallei. Additional studies
showed that uPAR deficiency did not influence hemostatic and
fibrinolytic responses during severe melioidosis.
Conclusions These data suggest that uPAR is crucially involved in
the host defense against sepsis caused by B. pseudomallei by
facilitating the migration of neutrophils towards the primary site of
infection and subsequently facilitating the phagocytosis of
B. pseudomallei.
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A comparison of acute lung inflammation in Klebsiella
pneumoniae B5055-induced pneumonia and sepsis in
BALB/c mice
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Department of Microbiology, Panjab University, Chandigarh, India
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Introduction Lungs play an important role in the body’s defense
against a variety of pathogens, but this network of immune system
mediated defense can be deregulated during acute pulmonary
infections.
Objective  The present study compares the acute lung inflam-
mation (ALI) occurring during Klebsiella pneumoniae B5055-
induced pneumonia and sepsis in BALB/c mice.
Methods  Pneumonia was induced by intranasal instillation of
bacteria (104 CFU) while sepsis was developed by placing the
fibrin–thrombin clot containing a known amount of bacteria
(102 CFU) into the peritoneal cavity of animals. Various cytokine
(TNFα and IL-1α) levels were estimated using ELISA and the
degree of lung inflammation (that is, inflammatory cell infiltration)
was evaluated by histopathological analysis. The other markers of
inflammation (that is, nitric oxide (NO), malondialdehyde (MDA)
and myeloperoxidase (MPO)) were estimated by standard
biochemical methods.
Results Mice with sepsis showed 100% mortality within 5 post
infection days whereas all the animals with pneumonia survived. In
animals suffering from K. pneumoniae B5055-induced pneumonia
all the inflammatory parameters (TNFα, IL-1α, MPO, MDA and NO)
were found to be maximum until the third post infection day, after
that a decline was observed, whereas in septic animals all the
above-mentioned markers of inflammation kept on increasing until
death of the animals. Histopathological study showed that
inflammatory damage to the lungs in pneumonia was not very
severe as lesser neutrophil infiltration and pulmonary damage (that
is, alveolitis, bronchiolitis, endothelitis and perivascular congestion)
was seen as compared with lungs taken from septic animals. This
can be further strengthened by the presence of alternatively
activated alveolar macrophages (AAMacs) or foam cells in lungs of
mice with pneumonia after the third post infection day and their
number kept on increasing until the seventh post infection day,
which might have contributed to the induction of resolution of
inflammation and clearance of the infection. But no such AAMacs
or foam cells were seen in lungs of septic mice on histo-
pathological examination, lungs were seen to be infiltrated with
only neutrophils on all experimental days.
Conclusions  Hence, during pneumonia controlled activation of
AAMacs or foam cells led to the resolution of inflammation and
infection as well.S2
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Performance evaluation and further development of the
PCR and microarray-based Prove-it™ Sepsis assay
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Introduction The Prove-it™ Sepsis assay is a rapid, broad-range
PCR and microarray-based assay designed to identify the majority
of sepsis-causing bacteria from positive blood cultures. The
pathogen panel covers 50 Gram-negative and Gram-positive
bacterial species (Table 1). It also reports methicillin resistance by
detecting the mecA gene. The assay time is 3 hours. Our objective
was to conduct a performance evaluation study for Prove-it™
Sepsis according to the EN 13612-standard (Performance
evaluation of in vitro diagnostic medical devices) and to compare
obtained results with those of current culture-based diagnostics.
We evaluated the sensitivity, specificity and time to result of Prove-
it™ Sepsis in two major teaching hospitals in Helsinki and London.
Materials  A total of 3,318 blood samples from patients with
suspected sepsis were collected. Blood culture bottles of
BacT/ALERT 3D (bioMérieux) and BACTEC 924 (Becton Dickinson)
were incubated for a total of 6 days or until flagged as positive.
Methods  DNA was extracted from blood cultures using the
automated DNA extraction instrument easyMAG (bioMérieux) prior
to the Prove-it™ Sepsis assay. Conventional blood culture was
conducted in parallel and results were only revealed for
comparison at the statistical analysis stage. Discordant results
were studied by DNA sequencing and case-by-case review of
original microbiology laboratory data.
Results Of the analyzed 3,318 blood cultures, 2,107 yielded a
pathogen by conventional techniques. Of these, 302 samples
contained microbes not covered by Prove-it™ Sepsis, and an
additional 137 cultures contained more than one organism.
Sensitivity and specificity for Prove-it™ Sepsis were 94.7% and
98.7%, respectively. Of particular significance was the assay’s
faultless ability to differentiate MRSA from MSSA and from CNS.
Furthermore, it provided results on average 1 day earlier than
reference methods.
Conclusions Prove-it™ Sepsis was considered to be a fast, robust,
and high-performance diagnostic platform, which is easily
implemented into everyday laboratory workflow. Both study sites
identified cases where timely information provided by Prove-it™
Sepsis would have significantly improved patient management.
Examples include more rational management and antibiotic choice
subsequent to earlier differentiation of Gram-positive cocci in
clumps into MRSA, MSSA, or CNS, and earlier speciation of
Gram-negative organisms. Prove-it™ Sepsis is further configured
for detection of Candida spp. and new bacterial targets. The assay
now identifies 60 out of the 302 samples not covered during the
evaluation, increasing the pathogen coverage from 86% to 89%.
The earlier speciation provided by Prove-it™ Sepsis could
contribute to faster, more evidence-based patient management
and, thus, positive outcomes.
Table 1 (abstract P3)
Bacteria and an antibacterial resistance marker identified by the Prove-it™ Sepsis assay
Gram-negative Gram-positive Antibacterial resistance
Neisseria meningitidis Staphylococcus aureus Methicillin resistance marker mecA
Enterobacter aerogenes Staphylococcus epidermidis
Enterobacter cloacae Coagulase-negative Staphylococcusd
Escherichia coli Streptococcus pyogenes
Klebsiella oxytoca Streptococcus agalactiae
Klebsiella pneumoniae Streptococcus dysgalactiae subsp. equisimilis
Proteus mirabilis Streptococcus pneumoniae
Proteus vulgaris Enterococcus faecalis
Salmonella enterica subsp. entericaa Enterococcus faecium
Serratia marcescens Listeria monocytogenes
Enterobacteriaceae familyb Clostridium perfringens
Acinetobacter baumannii
Pseudomonas aeruginosa
Stenotrophomonas maltophilia
Haemophilus influenzae
Campylobacter jejuni/coli
Bacteroides fragilis groupc
aSalmonella enterica subsp. enterica covers at least the following serovars: Enteritidis, Oranienburg, Othmarschen, Paratyphi, Stanley, Typhi, Typhimurium,
Virchow, Group A, B, C, D. bEnterobacteriaceae covers at least the following species: Citrobacter amalonaticus, Citrobacter freundii, Citrobacter koseri,
Citrobacter braakii, Enterobacter hormaechei, Enterobacter sakazakii, Kluyvera intermedia, Morganella morganii, Pantoea agglomerans, Providencia rettgeri,
Providencia stuartii, Yersinia enterocolitica, Yersinia pseudotuberculosis. cBacteroides fragilis covers at least the following species: B. fragilis, B. vulgatus,
B. thetaiotaomicron. dCoagulase-negative Staphylococcus covers at least the following species: S. capitis, S. lugdunensis, S. haemolyticus, S. hominis, S.
saprophyticus, S. warneri, S. xylosus.S3
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Nandrolone abuse aggravates septic shock
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Critical Care 2009, 13(Suppl 4):P4 (doi: 10.1186/cc8060)
Introduction One million individuals in the United States alone are
estimated to be current or past users of anabolic-androgenic
steroid.
Methods  To investigate the effects of nandrolone, an anabolic-
androgenic steroid, 108 6-week-old male BALB/c inbred mice
were used (minimal lethal dose n = 30, high-dose vs. low-dose
n = 24, screening surrogates n = 6, and surrogates n = 48). Mice
were sacrificed at 0, 3 or 6 hours after septic shock induction. The
serum levels of malondialdehyde, liver TNFα and spleen IFNγ in
mice with septic shock were analyzed. The gene expression of
insulin-like growth factor 1, insulin-like growth factor type 1
receptor and insulin-like growth factor binding proteins was also
studied.
Results  Nandrolone significantly increased serum malondialde-
hyde at 0, 3 and 6 hours (P = 0.004, 0.006 and 0.004), and liver
TNFα at 0 and 6 hours (P = 0.04 and 0.016). It also increased the
spleen IFNγ level at 0 and 6 hours (P = 0.031 and 0.01). Com-
pared with 0 hours, the data indicated that nandrolone increases
lung insulin-like growth factor type 1 receptor, insulin-like growth
factor binding protein 1 and insulin-like growth factor binding
protein 2 mRNA expression at 6 hours (P <0.05). These indicated
changes due to nandrolone.
Conclusions  Nandrolone abuse hastens mortality due to septic
shock and increases serum malondialdehyde, liver TNFα, spleen
IFNγ level and lung insulin-like growth factor type 1 receptor
mRNA, as well as lung insulin-like growth factor binding proteins.
Nandrolone abuse may aggravate septic shock.
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Use of a screening authorization and randomization center
for severe sepsis patient qualification and real-time
enrollment in a phase 2 trial of eritoran tetrasodium
(E5564), a TLR4 antagonist
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Introduction Trials of many promising sepsis modifiers have often
failed to demonstrate benefits because of, among other reasons,
poor characterization of enrolled patients.
Materials  Advantages of utilizing a screening authorization and
randomization center (SAC) method to characterize patients in
trials for sepsis modifiers are presented.
Methods A central SAC on call 24 hours per day was employed in
a phase 2, double-blind, randomized comparison of eritoran 45
and 105 mg versus placebo. SAC activities were conducted
(January 2002 to April 2005) by six clinical pharmacists. Severe
sepsis was defined with at least three systemic inflammatory
response syndrome criteria within 12 hours before onset of ≥1
new organ dysfunction. Patients were randomized and treated
within 8 to 12 hours. The 8-hour to 12-hour window for qualifi-
cation and start of treatment was the primary challenge to the SAC
and study sites. Each site used two sequences of drug assignment
based on Acute Physiology and Chronic Health Evaluation
(APACHE) II predicted mortality to yield a balanced allocation of
high and low APACHE II predicted mortality within the three
treatment groups: one sequence for subjects with APACHE II
predicted mortality 20 to 50%, and another for subjects with
predicted mortality 51 to 80% as calculated by the SAC.
Results  The SAC screened 1,025 patients from 78 sites; 300
patients from 54 sites were randomized, and 293 were treated.
The Independent Clinical Evaluation Committee subsequently
qualified 229/293 (78%). Calls to the SAC averaged 24 patients/
month; eight patients/month were randomized (33%). Enrollments
ranged from 0 to 39 patients/site; 35 sites randomized ≥3 patients;
nine sites randomized ≥10 patients. Of 35 sites with ≥3 patients,
6 to 100% led to randomization.
Conclusions  Advantages of utilizing the SAC included a high
evaluable rate of enrolled patients, correct Predicted Risk of
Mortality calculations, timing of qualifying organ failures, drug
preparation advice, verification of key clinical data, and eligibility
with sponsor prior to enrollment. SAC activities ensured an
informative phase 2 trial and will be utilized for the phase 3 trial.
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Influence of severity of illness on the effects of eritoran
tetrasodium (E5564), a TLR4 antagonist, in patients with
severe sepsis
SM Opal1,AC Kalil2, SP LaRosa1, J Gogate3, M Lynn3, 
AE Wittek3,and the Eritoran Sepsis Study Group
1Brown University, Providence, RI, USA; 2University of Nebraska
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Introduction Disease severity varies widely in patients with severe
sepsis. Previous trials (IL-1RA, TNF-sR p55, antithrombin, and
drotrecogin alfa activated (DAA)) suggest that more severely ill
patients benefit most from treatment.
Objective The aim of this study was to evaluate the efficacy of
eritoran for interaction effects with baseline illness severity.
Methods Prospective covariates from a randomized, double-blind,
placebo-controlled, phase 2 trial were analyzed for treatment
interaction measured by 28-day mortality. Breslow–Day and
multiple logistic regression (LR) were used to assess categorical
(CAT) and continuous (CONT) treatment by severity-of-illness
interactions.
Results Modified intent-to-treat population (n = 292) all-cause 28-
day mortality was: placebo, 33.3% (32/96); total eritoran 45
mg/105 mg, 29.6% (58/196). LR analysis identified Acute
Physiology and Chronic Health Evaluation (APACHE) II scores,
Predicted Risk of Mortality (PROM) scores, IL-6, age, sex, race,
and eritoran as associated with survival outcomes. Significant
treatment interactions were observed (eritoran vs. placebo) for
baseline covariates: APACHE II (CAT, P= 0.059; CONT, P= 0.035);
PROM scores (CAT, P = 0.028; CONT, P = 0.008); number of
organ failures (CAT, P = 0.079); international normalized ratio
(CAT, P = 0.05); and acute physiology score (CONT, P = 0.039).
No significant treatment interactions were observed with age, sex,
shock, DAA use, infection site, microorganism type, platelets, IL-6,
or endotoxin levels. Interaction results were similar for eritoran
105 mg only versus placebo.
Conclusions Potential survival benefits of eritoran in severe sepsis
patients may be associated with high severity of illness. Treatment
by disease severity interaction will be further explored in a phase 3
trial.S4
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Introduction  Frequent usage of medical devices, such as
intravenous lines, often results in sepsis, which is characterized by
high morbidity and mortality. Rapid and reliable detection and
differentiation between Staphylococcus aureus and coagulase-
negative Staphylococci (CNS) is therefore clinically relevant to be
able to provide adequate early treatment. Blood culture is still the
gold standard method in identifying these pathogens but is time
consuming. Molecular diagnostics might be a promising alternative
to reduce this time-to-result delay.
Objective  This study aims to compare different DNA extraction
methods from two commonly used blood culture materials, BACTEC
(BD) and Bact/ALERT (Biomerieux), to accelerate differentiation
between S. aureus and CNS.
Methods Two fast real-time PCR duplex test assays, targeting the
Tuf gene, to differentiate S. aureus from CNS, were developed in
order to select the most sensitive one. This Tuf RT-PCR was used
to compare three different DNA isolation methods on two different
blood culture systems. Negative blood culture material was spiked
with  S. aureus; bacterial DNA was isolated with: automated
extractor EasyMAG (Biomerieux), automated extractor MagNA
Pure (Roche), and a manual kit MolYsis Plus (MolZyme).
Results  The best Tuf RT-PCR method appeared to have a
sensitivity of 100 CFU/ml. Approximately 50 positive blood cultures
containing Gram-positive cocci in clusters were tested in the Tuf
RT-PCR and all were identified correctly. Bacterial DNA isolation,
from spiked blood culture material, with the EasyMAG showed the
highest analytical performance with a detection limit of 103 CFU/ml
in Bact/ALERT material, whereas using BACTEC resulted in a
detection limit of 104 CFU/ml. Hand-on time, for 26 samples, was
lowest for the EasyMAG (10 minutes) and highest for the manual kit
of MolZyme (2 hours). Total handling time was highest for the
MolYsis Plus kit (3.5 hours) and lowest for the automated extractor
EasyMAG (50 minutes).
Conclusions A sensitive RT-PCR was developed for detection and
differentiation of S. aureus versus CNS. Bacterial DNA isolation
from Bact/ALERT blood culture material seems to show better
reproducibility compared with isolation from BACTEC blood
culture material. In this preliminary study the EasyMAG performed
better when compared with MolYsis Plus and the MagNA Pure
system. In future work this method will be further evaluated with
reduced culture times.
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Effect of canine hyperimmune plasma on TNFα α and
inflammatory cell levels in a lipopolysaccharide-mediated
rat air pouch model of inflammation
B Essien, M Kotiw, H Buttler, D Strunin
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Introduction  Unregulated elevated levels of serum TNFα have
been associated with proinflammatory cytokine cascades that are
characteristic in diseases such as septic shock. Endotoxic shock,
which has a poorer prognosis than found with other forms of septic
shock, is mediated by lipopolysaccharide (LPS), a molecule that is
released from the outer membrane of Gram-negative bacteria. LPS
is a potent stimulator of TNFα secretion by serum monocytes and
tissue macrophages. Whilst the use of monotherapeutic TNFα
antagonists has been trialed, none have been registered for use in
patients with sepsis.
Objective  The purpose of this study was to test the effect of
canine hyperimmune frozen plasma (HFP), which is known to
contain elevated levels of soluble TNFα receptor 1 (sTNFR1), on
TNFα and inflammatory cell levels in a LPS-mediated rat air pouch
model of inflammation.
Methods A dorsal air pouch in 175 to 200 g Sprague–Dawley rats
was formed by 20 ml subcutaneous infusions of sterile air.
Prophylactic subcutaneous injections of canine HFP, canine fresh
frozen plasma (FFP) or carprofen were administered daily for
3 days into the lateral flank of the right foreleg at doses recom-
mended by the manufacturers (n = 10 for each treatment group).
Pouch fluid was harvested by syringe at 1, 6, 12, 24 and 48 hours
post LPS administration and subjected to histological and
cytokine/cytokine receptor analysis. TNFα and sTNFR1 levels were
determined by ELISA and an immunofluorescent dot blot assay.
Results  Pouch fluid analysis: maximal effects were detected at
6 hours post LPS administration. TNFα levels were significantly
depressed in animals dosed with HFP, but not in animals treated
with FFP or carprofen (P <0.05). sTNFR1 levels were significantly
elevated in HFP, but not in FFP or carprofen dosed animals
(P <0.05). Neutrophil numbers were significantly depressed in
HFP dosed but not in FFP or carprofen treated animals (P <0.05).
Conclusions There appears to be a correlation between elevated
levels of sTNFR1 and depression of TNFα and neutrophil levels in
the pouch fluid of HFP dosed rats (r = –0.73, P <0.0001). The
data suggest that canine HFP, which has been demonstrated to
contain elevated levels of sTNFR1 compared with FFP, has a direct
effect on depressing TNFα levels and neutrophil sequestration in
the rat air pouch model of inflammation. These data suggest that
HFP may be worthy of further investigation to determine whether
such preparations have a therapeutic potential for treatment of
acute inflammatory diseases in which TNFα is implicated.
P9
Clinical impact of a PCR-based assay for pathogen
detection in critically ill patients with evidence of infection
F Bloos1, A Kortgen1, S Sachse2, M Lehmann3, E Straube2, 
K Reinhart1, M Bauer1
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GmbH, Jena, Germany
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Introduction  Blood cultures are often negative even in patients
with clinical signs of severe sepsis. Furthermore, the long time to
result of culture-based methods does not allow the results to guide
empiric antimicrobial therapy. PCR-based pathogen detection
promises a higher rate of positivity and a faster time to result.
Objective  To report the performance of PCR-based pathogen
detection compared with blood culture in ICU patients with evidence
of infection, and the impact of this test on the antimicrobial therapy.
Methods  Patients treated on an interdisciplinary ICU were
included into this observational study if a blood culture (BC) was
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drawn on discretion of the treating physician. Blood cultures and
EDTA-blood were taken by sterile venous puncture. The EDTA-
blood was processed with a PCR-based assay (VYOO®; SIRS-
Lab GmbH, Jena, Germany), which detects a panel of 34 bacterial
and six fungal pathogens as well as five antibiotic resistances. Data
are given as median and interquartile range.
Results Sixty-three patients were included into this study. Age was
68.0 (55.5 to 74.0) years, APACHE II score was 17 (13 to 23),
SOFA score at study inclusion was 10.0 (7.50 to 11.0), and ICU
mortality was 33.3%. In 54 patients (84.3%) infection was either
microbiologically confirmed or clinically proven. The baseline
procalcitonin was 2.4 (0.8 to 8.0) ng/ml. Eighty-two pairs of BCs
and PCRs have been drawn. Ten (12%) BCs and 30 (36.6%)
PCRs were positive (P <0.001). Time to test result was
significantly shorter in the PCR than in the BC (Figure 1). Twelve
positive PCR results (Figure 2, grey areas) prompted a change in
antibiotic or antimicrobial therapy.
Conclusions  The PCR-based assay resulted in a considerably
higher amount of positive results within a shorter time to result than
the BC in this group of high-risk patients with evidence of infection.
These data demonstrate that the shorter time to result may guide
adjustment of antimicrobial therapy earlier than culture-based
methods. Further studies are necessary to prospectively investi-
gate the impact of the PCR technique on antimicrobial therapy and
infection control.
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Comparison of commercial DNA extraction kits for the
detection of bacterial genomic DNA from whole-blood
samples using a broad-range PCR
B Krulova, E Nemcova, B Zaloudikova, P Nemec, T Freiberger
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Introduction Blood culture is still considered a gold standard for
diagnosis of bloodstream infections. Early pathogen detection is a
prerequisite for the successful treatment. Nucleic acid based
techniques offer a rapid and sensitive option particularly in blood
culture negative samples. Efficient bacterial DNA extraction is
crucial for following PCR assays. The aim of this study was to
determine the detection limit of bacterial genomic DNA using
different extraction protocols.
Methods  We evaluated five commercially available kits for the
extraction of bacterial genomic DNA from whole-blood samples
(QIAamp DNA Blood Mini kit, UltraClean DNA BloodSpin Kit,
Chemagic DNA Blood Kit, ZR Genomic DNAII Kit, NucliSens
miniMAG). Whole-blood samples were spiked with Escherichia
coli CCM 3988 and Staphylococcus aureus CCM 7111. Tenfold
dilution series containing concentrations from 107 to 100 CFU/ml
were prepared under sterile conditions and immediately used. A
broad-range 16S rDNA end-point PCR was performed for the
detection of E. coli and S. aureus DNA.
Results The sensitivity of each kit was determined as a minimum
rate of CFU providing the positive result in the PCR assay. Our
results showed the extraction by the QIAamp DNA Blood Mini Kit
(supplemented with enzymatic pre-treatment) as the most efficient
and sensitive method. This extraction protocol allowed the
reproducible detection of E. coli and S. aureus at concentrations
of 103 CFU/ml. All kits showed positive results in samples at
concentrations from 107 to 105 CFU/ml.
Conclusions Extraction kits should be capable to recover nucleic
acids and remove inhibitors from diverse clinical materials
simultaneously. All of the tested kits were able to recover bacterial
genomic DNA from whole-blood samples, but the sensitivity of PCR-
based detection depends on the DNA extraction protocol used.
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Toll-like receptor 9-dependent gene expression in vivo is
regulated by inductive and suppressive networks
S Klaschik1,2, D Tross2, DM Klinman2
1Department of Anesthesiology and Intensive Care Medicine,
University of Bonn, Germany; 2Cancer and Inflammation Program,
NCI Frederick, MD, USA
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Introduction  Synthetic oligodeoxynucleotides (ODN) expressing
CpG motifs mimic the immunostimulatory activity of bacterial DNA.
CpG ODN interact with Toll-like receptor 9 to stimulate an innate
immune response characterized by the production of Th1 and
proinflammatory cytokines, and the functional maturation of
Available online http://ccforum.com/supplements/13/S4
Figure 1 (abstract P9)
Figure 2 (abstract P9)S6
immune cells. Changes in gene expression mediated by the in vivo
administration of CpG ODN were identified using microarrays.
Objective We predicted that microarrays could be used to identify
reproducible changes in gene expression induced by CpG ODN
activation in mice treated in vivo over time, and that network
analysis would allow us to identify regulators of gene expression.
Materials  cDNA was generated from total RNA isolated from
spleen cells of mice 30 minutes to 3 days after in vivo treatment
with 400 μg CpG or control ODN.
Methods Dual-color hybridizations (Biomicro) were performed on
murine genome microarrays (NCI). Analyses were conducted on
four independently derived RNA samples for each time point. R2
was 0.90 ± 0.04 for all matched samples. Network analysis was
performed using Ingenuity Pathway Analysis.
Results Differential gene activation (P <0.00001) was observed
within 30 minutes of CpG ODN treatment (25 genes), peaked at
3 hours (529 upregulated genes), and fell to near background
levels after 72 hours. TNFα, IL-1β, NF-κB and IFNγ played central
roles in upregulating the early expression of immune-related genes.
Of interest, two distinct patterns of gene expression were
observed. One subset of genes was activated shortly after CpG
ODN administration and remained upregulated for a prolonged
period, while unique subsets of additional genes were activated at
specific time points, and were rapidly downregulated. Several
genes responsible for this downregulation (MYC, IL1RN, SOCS1)
were identified.
Conclusions This analysis identifies two distinct patterns of gene
regulation associated with CpG-induced activation of the innate
immune system of mice. A small number of regulatory genes
triggers the patterned upregulation of immune related genes from
30 minutes through 72 hours. A separate set of downregulatory
genes subsequently dampens what would otherwise be a
continuous positive feedback loop.
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Fluid therapy in severe sepsis: results from a
representative survey of German ICUs
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Introduction  Fluid resuscitation is a mainstay of sepsis
management.
Objective  To describe the practice of fluid therapy in German
ICUs.
Methods Analysis of data derived from the SepNet cross-sectional
1-day point-prevalence study of patients with sepsis [1]. ICU
directors were asked about their fluid preferences. Data on days
after start of sepsis were adjusted to account for overestimation of
long-stayers in a point-prevalence survey. SPSS 15.0.1 (SPSS,
Chicago, IL, USA) was used; the chi-square test or Kruskal–Wallis
H test was applied where appropriate.
Results  On operative ICUs, more patients received synthetic
colloids (41.4 vs. 21.2%, P  <0.001) and crystalloids (74.6 vs.
65.0%, P <0.05), while albumin use did not differ. ICU directors of
operative ICUs stated using synthetic colloids more frequently and
albumins less frequently than their colleagues from nonoperative
ICUs. Stated and actual fluid use did not differ by hospital size. Of
415 patients with severe sepsis, 71.6% received crystalloids.
35.2% synthetic colloids (HES; gelatin, dextran), 16.4% received
5% glucose, and 4.1% albumin solutions. HES was the most
frequently used colloid. It was administered to 29.4% of patients
as HES 10% in 10.4% (mean dose, 787.8 ± 420.0 ml/24 hours)
and as HES 6% in 20.7% (mean dose, 769.1 ± 403.1 ml/24 hours).
Patients receiving HES had a higher mean SOFA score than
patients without HES (9.92 ± 4.12 vs. 8.00 ± 4.07, P <0.001),
tended to more frequent acute renal failure (ARF) (defined as serum
creatinine >1.5 mg/dl (132.6 μmol/l) and diuresis ≤500 ml/day, no
chronic replacement therapy, RRT), more RRT, lower thrombocyte
counts and more frequently received RBCs, but this was non-
significant. In total, 29.5% of patients with ARF and 30.3% of
patients with RRT received HES. HES was administered to 115
patients between day 0 and day 63 after the start of severe sepsis.
Conclusions Fluid therapy in septic patients varied by type of ICU.
About 30% of patients received HES regardless of renal
dysfunction. HES was applied for many days after the start of
severe sepsis.
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Introduction  The migration of polymorphonuclear neutrophils
(PMN) into inflamed tissue requires fine interactions with the
endothelial cell surface. The PMN serine proteases cathepsin G
(CG), neutrophil elastase (NE) and proteinase 3 (PR3) were
originally thought to play a role by the cleavage of endothelial cell
proteins that control the PMN firm adhesion and the
transendothelial cell migration. However, how these proteases
participate in leukocyte adhesion and transmigration remains
controversial. Vascular endocan, also called esm1, is a restricted
endothelial cell-secreted proteoglycan constituted by a protein
core of 20 kDa and by a unique glycosaminoglycan chain of
dermatan sulphate (DS). Endocan is preferentially expressed in
lung and kidney tissues. Endocan binds to its leukocytic receptor,
the LFA-1 integrin, with an affinity of 18 nM, and inhibits the
LFA-1–ICAM-1 interactions. Its expression is upregulated by the
proinflammatory mediators TNF, IL-1, and lipopolysaccharide. In
human sepsis, the serum endocan increases from fivefold to
30-fold the normal value and correlates with bad prognosis. Here,
we examined the role of PMN-derived proteases in the degradation
of endocan.
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Methods Human endocan is produced by overexpressing HEK
293 cell lines and purified by anion exchange and affinity
chromatographies. Proteolysis is performed by addition of endocan
with PMA-activated PMN supernatants, purified CG, NE, or PR3.
Endocan degradation is evaluated by ELISA, western blot and
MALDI-TOF mass spectrometry. Binding assay on Jurkat cells is
performed as described previously. Endocan-derived p14
fragments in human serum were detected by immunoprecipitation.
Results  We demonstrate that CG, NE but not PR3 degrade
endocan. We show that the degradation profiles of endocan by
CG or NE are different. We interestingly identify a novel peptide
fragment of endocan of 14 kDa, named p14, which represents the
main endocan degradation product. This p14 results from the
specific cleavage of the full-length endocan by CG. The generation
of this particular fragment strictly required the presence of the DS
chain on full-length endocan. Furthermore, this p14 fragment
becomes resistant to NE. We also demonstrate that p14 inhibits
the binding of endocan to Jurkat cells. Finally, we present evidence
that p14 could be detected in patient serum suffering from an
acute PMN-mediated disease like sepsis.
Conclusions The results suggest that the expression of CG by
PMN shortly after their activation, by modifying the micro-
environment in degrading vascular endocan, may participate in the
complex network that controls tissue infiltration of leukocytes
during sepsis.
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Introduction  Intravenous catheter-related bloodstream infections
(ICR-BSI) are a major contributing factor to in-hospital mortality
and morbidity extending inpatient stay by 10 days and expenditure
per patient by £2,000 to £30,000 [1].
Objective A prospective survey was conducted in our unit on all
patients with central venous catheters to ascertain the incidence of
ICR-BSI, identify the organisms and determine the occurrence of
infection from the various sites – femoral, internal jugular and
subclavian lines.
Methods The survey was carried out over a period of 13 weeks.
Data collected from patients’ case notes included site of central
line insertion, length of line in situ, reason for line removal and
positive blood culture reports.
Results During the study period, 104 patients were treated on the
unit. Fifty-two central venous lines were inserted in 36 patients
(Figure 1): 63.5% femoral (n = 33), 32.7% internal jugular (n = 17)
and 3.9% subclavian lines (n = 2) (Figure 2). The lines were
reviewed daily and removed if indicated clinically (pyrexia or raised
white cell count) or if not required. A total 51.5% of femoral lines
(n = 17) were removed due to clinical indications, as were 29%
(n = 5) of internal jugular and 50% (n = 1) of subclavian lines. The
average duration of a line remaining in situ was 4.5 days for
femoral, 6 days for internal jugular and 5 days for subclavian lines
(Figure 3). Blood cultures were taken at the time of line removal.
These yielded positive results in eight femoral, seven internal
jugulars and one subclavian line (Figure 4). Our survey indicated
that the incidence of ICR-BSI in our unit is 30.8%, (of this 62.5%
coagulase-negative staphylococci (CNS), 12.5% Escherichia coli
and  Pseudomonas each, and 6.25% MSSA and MRSA each)
(Figure 5).
Conclusions  The distribution of microorganisms causing
bacteraemia is broadly similar in our unit to that in other teaching
hospitals in the UK [2], in that CNS was the commonest organism
isolated. However, E. coli and  Pseudomonas were the next
common organisms, unlike other units where Staphylococcus
aureus was the second most prevalent organism. The incidence of
bacteraemia from femoral lines (53.7/1,000 catheter-days) was
lower than that from internal jugular lines (68.6/1,000 catheter-
days) possibly due to a higher index of suspicion in the case of
femoral lines and earlier removal (Figure 6). Our study highlights
Available online http://ccforum.com/supplements/13/S4
Figure 1 (abstract P17)
Age distribution of patients in WCNN intensive therapy unit.
Figure 2 (abstract P17)
Distribution of central venous catheters in WCNN intensive therapy
unit.
Figure 3 (abstract P17)
Average duration of central venous catheters in WCNN intensive
therapy unit.S8
the fact that femoral lines, which are often the safest option for
unstable patients with head injury, can be effectively managed with
strict adherence to guidelines to reduce ICR-BSI.
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Introduction  Continuous heart rate variability (HRV) monitoring
can detect early sepsis in certain high-risk patient populations, but
the mechanisms by which sepsis depresses HRV are not well
understood. Our prior studies in rodents have shown that endo-
toxin causes cytokine-related depression of HRV and activation of
specific neuronal networks. The aim of the current studies was to
identify pathogen-specific patterns of cytokine expression, HRV
changes, and activation of central autonomic pathways in mice.
Materials and methods Adult male C57BL/6 mice implanted with
radiotelemetry probes for continuous ECG and temperature
monitoring were inoculated intraperitoneally with Klebsiella pneumo-
niae (KP,  n= 21), methicillin-resistant Staphylococcus aureus
(MRSA-COL, n = 9) or Candida albicans (CA-SC5314, n = 2). Heart
rate variability (standard deviation of RR intervals) was measured
continuously for up to 3 days in K. pneumoniae and MRSA mice and
up to 3 weeks in CA mice. Blood was obtained at two or more time
points for culture and measurement of G-CSF, KC, MIP-1β, IFNγ,
TNFα, IL-6, and IL-10. Neuronal activation was assessed in multiple
brain regions of K. pneumoniae-infected mice by c-Fos staining.
Results  Compared with sham-treated mice, infected mice had
increases in multiple cytokines at 18 hours and 42 hours post
inoculation. Cytokine profiles were similar among the three
organisms except that CA-infected mice expressed less KC.
Bacteria-inoculated mice with adverse outcome (positive blood
culture and/or death, n = 8 of 21 K. pneumoniae and 3 of 9
MRSA) had significantly higher levels of all cytokines compared
with mice with good outcome. Substantial depression of HRV was
seen in all 11 bacteria-infected mice with adverse outcome and in
only one of 19 mice with good outcome. Levels of G-CSF and IL-6
were negatively correlated with HRV (Spearman correlation
coefficient = –0.36 and –0.37, respectively, P = 0.05 for each)
and there was a trend toward a correlation with KC (–0.35,
P = 0.07). Immunohistochemical studies revealed that, compared
with sham-treated controls (n = 2), K. pneumoniae infection (n =3 )
was associated with c-Fos induction in the dorsal vagal complex
and ventrolateral medulla, paraventricular hypothalamic nucleus,
preoptic area, subfornical organ, bed nucleus of the stria terminalis,
and medial prefrontal and insular cortices. c-Fos immunoreactivity
also occurred in ventricular ependymal cells and in cells associated
with large blood vessels.
Conclusions  Infection with Gram-positive or Gram-negative
bacteria invokes similar changes in cytokines and HRV in mice,
whereas preliminary studies suggest Candida infection results in
different patterns. K. pneumoniae infection causes widespread
neuronal activation within the central autonomic network.
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Introduction Affecting the γ-amino butyric acid (GABA) pathway
results in an alteration of inflammatory response in various animal
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Figure 4 (abstract P17)
Distribution of ICR-BSI in WCNN intensive therapy unit.
Figure 5 (abstract P17)
Distribution of ICR-BSI organisms in WCNN intensive therapy unit.
Figure 6 (abstract P17)
Incidence of ICR-BSI in WCNN intensive therapy unit.S9
models. However, its mechanism is still unclear. The aim of this
study was to determine the effects of muscimol, a GABAA
receptor agonist, on lipopolysaccharide-induced mortality and
inflammation in mice.
Materials C57BL6 mice, lipopolysaccharide (derived from Escher-
ichia coli, serotype O55:B5), and muscimol were used in this study.
Methods Mice endotoxemia was induced by 10 mg/kg lipopoly-
saccharide intraperitoneally. Muscimol ranging from 0 to 3 mg/kg
was given subcutaneously 30 minutes before lipopolysaccharide
administration. Serum TNFα, IL-1β, IL-10, and IL-12 were
determined using ELISA.
Results Muscimol significantly increased the survival rate in sub-
lethal dose of lipopolysaccharide-treated mice (from 7% to 100%)
(P < 0.0001) within 72 hours. Muscimol inhibited serum TNFα,
IL-1β, and IL-12 production in a dose-dependent manner. Further-
more, muscimol significantly increased serum IL-10 levels
(P < 0.001) in lipopolysaccharide-treated mice.
Conclusions  Muscimol potently increased the survival rate and
inhibited inflammatory response in endotoxemic mice.
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Introduction  Hypotension is well relative to the high mortality of
sepsis. Sesamol increases the survival rate of septic mice. However,
the effect of sesamol on septic hypotension after the onset of
systemic inflammation has never been studied. The aim of the study
is to investigate the effect of sesamol on septic hypotension.
Materials Wistar rats, lipopolysaccharide (LPS) (derived from Escher-
ichia coli, serotype O55:B5), and sesamol were used in this study.
Methods Hypotension was induced by injecting LPS intravenously.
Mean arterial pressure was measured using an invasive blood
pressure system. Serum nitrite and cytokine levels were deter-
mined using the Griess reaction and ELISA, respectively.
Peroxisome proliferator-activated receptor (PPAR) activation was
measured using a PPAR assay kit.
Results  LPS administration significantly increased the serum
TNFα level at 1 hour. Sesamol treated 1 hour after LPS adminis-
tration inhibited the LPS-associated blood pressure decrease.
Sesamol failed to decrease the LPS-induced nitrite production, but
decreased the LPS-induced TNFα and IL-1β production after the
onset of systemic inflammation. Sesamol enhanced the IL-10
production in serum and the PPAR activation in white blood cells.
Conclusions Sesamol may attenuate septic hypotension through
alternating cytokine production by PPAR activation after the onset
of systemic inflammatory response.
P21
3,4-Methylenedioxyphenol attenuates systemic
inflammation and oxidative stress in septic rats
Y-H Li, D-Z Hsu, M-Y Liu
Department of Environmental and Occupational Health, National
Cheng Kung University Medical College, Tainan, Taiwan
Critical Care 2009, 13(Suppl 4):P21 (doi: 10.1186/cc8077)
Introduction  Sepsis is one of the major causes of mortality in
ICUs. Systemic inflammation and oxidative stress are involved in
the pathogenesis and development of sepsis. 3,4-Methylene-
dioxyphenol (sesamol), one of the lignans in sesame oil, protects
against endotoxin-induced oxidative stress and organ failure.
However, the effects of sesamol on systemic inflammation and
oxidative stress in septic rats have never been investigated.
Objective To investigate the effects of sesamol on systemic inflam-
mation and oxidative stress in septic rats.
Methods Septic rats were induced by cecal ligation and puncture
(CLP). Rats received sesamol (10 mg/kg, subcutaneously) 0 and
6 hours after CLP. IL-1β, lipid peroxidation, hydroxyl radical, super-
oxide anion, xanthine oxidase activity, and nitrite levels in blood
were determined 12 hours after CLP.
Results IL-1β, lipid peroxidation, hydroxyl radical, superoxide anion,
xanthine oxidase activity, and nitrite levels were significantly
increased in CLP-treated rats compared with those in the sham-
operation group (all P <0.05). Sesamol significantly reduced IL-1β,
lipid peroxidation, hydroxyl radical, superoxide anion, xanthine
oxidase activity, and nitrite levels compared with the saline group in
CLP-treated rats (all P <0.05).
Conclusions Sesamol might attenuate systemic inflammation and
oxidative stress by inhibiting proinflammatory cytokine and reactive
oxygen species generation in septic rats.
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Introduction Central venous catheter (CVC)-related bloodstream
infections (CRBSI) are the third most common healthcare-
associated infection (HAI) in ICUs, associated with significant
morbidity, mortality, increased length of stay and costs [1,2].
Several care bundle studies have suggested that utilising various
strategies together (such as training, regular line monitoring and
using dedicated line insertion trolleys) can have a positive impact
on CRBSI rates [3-6]. However, the impact solely attributable to
the provision of a dedicated, stand-alone CVC insertion pack has
not been evaluated. We therefore investigated the impact of a new
EPIC2 compliant CVC pack, introduced in Good Hope Hospital in
2007, on CVC tip colonisation rates.
Methods Data were collected prospectively between June 2007
and December 2008. Patients were divided into two cohorts:
patients whose CVCs were inserted using the CVC packs (B), and
those receiving CVCs prior to the introduction of the packs (nB).
Data were collated from questionnaires as well as patients’ notes
on: patient’s age and sex; type and site of CVC inserted; location at
the time of insertion; the grade of practitioner; and the duration
CVCs remained in situ. Using the hospital’s patient information
system and patient notes, data on CVC tip cultures were obtained.
Data are presented as percentages and analysed using multivariate
analysis.
Results  Complete data were obtained for 347 patients: 246
patients in group nB, 101 patients in group B. Male/female ratio,
average age, site of insertion, clinical area of insertion and grade of
practitioner were similar in both cohorts. There was a significantly
higher number of 5-lumen catheters inserted in group B compared
with group nB (81% compared with 44%, P <0.05), reflecting
change in hospital practice. More B catheters (51%) were left in
situ longer, for 6 to 10 days, compared with nB catheters (31%)
(Figure 1). Thirty-one per cent of nB tips grew colonies of at least
one pathogen. There was a significant reduction in the number of
B tips growing colonies (12% compared with 31%, P <0.05)
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(Figure 2). The bundle cohort had no MRSA growth compared with
four incidences in the nB group.
Conclusions Our results indicate that use of dedicated CVC packs
was associated with a significant reduction in the colonisation rate
of CVCs, despite lines being left in situ for longer periods and the
more frequent use of quin-lumen catheters in the intervention group.
There was also a trend toward prevention of MRSA colonisation.
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Introduction Klebsiella species are opportunistic pathogens that
can give rise to severe infections including pneumonia and sepsis.
Typically, Klebsiella infections are nosocomial and mainly caused
by Klebsiella pneumoniae, the medically most important species of
the genus.
Objective We set out to validate and extend our previous data using
C3H/HeJ mice that demonstrated an important role for TLR4 in K.
pneumoniae pneumonia. Moreover, we were interested in the relative
roles of cells from hematopoietic origin and parenchymal cells.
Methods  Using TLR2 and TLR4 single and TLR2x4 double
knockout (KO) mice on a C57BL/6 background, the roles of TLR2
and TLR4 were investigated independently and together. We
intranasally inoculated C57BL/6 wild-type (WT) and KO mice with
K. pneumoniae (4 x 10–3 CFU per mouse) and studied host
defense. Moreover, we performed bone marrow transplantation
(BMT) experiments in which we transplanted KO bone marrow into
irradiated WT mice and vice versa.
Results  Shortly after infection, both TLR4 and TLR2x4 KO mice
demonstrated an attenuated proinflammatory response in the lungs.
This was associated with higher bacterial counts 24 hours after
infection in the lungs, liver and spleens of both TLR4 and TLR2x4
KO animals. Interestingly, although no differences in antibacterial
host defense of TLR2 KO animals were observed, TLR2x4 KO
animals were more susceptible to K. pneumoniae infection than the
single TLR4 KO mice: after 44 hours of infection, 0/8 WT, 0/8 TLR2
KO mice, 5/8 TLR4 KO mice and 8/8 TLR2x4 KO mice had
succumbed. Moreover, when infecting all strains with a high dose of
K. pneumoniae (10–4 CFU), no differences in outgrowth were
detected between WT, TLR2 and TLR4 KO animals, whereas
double KO animals suffered from higher bacterial burdens in the
lungs, liver, spleen and blood. BMT of WT bone marrow into irradiated
TLR2x4 KO mice resulted in a reversed phenotype with similar
bacterial growth compared with syngenic transplanted WT mice.
Conclusions  These data confirm our previous research that,
during low-dose infections, TLR4 is of primary importance in host
defense against K. pneumoniae. Nevertheless, when high numbers
of bacteria are present, TLR2 acts together with TLR4 to
orchestrate the immune response, a protective effect that is
primarily mediated by hematopoietic cells.
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Introduction The pandemic by the novel H1N1 virus has created
the need to study any probable effects of that infection in the
immune system of the host.
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Figure 1 (abstract P22)
Number of days CVCs were left in situ in both cohorts.
Figure 2 (abstract P22)
Differences in colony growth in the two cohorts. *P <0.05.S11
Methods  Blood was sampled within the first 2 days of the
presentation of signs of infection from 10 healthy volunteers; from
18 patients of flu-like syndrome (FLS); and from 30 patients of
infection by H1N1 confirmed by reverse RT-PCR. Absolute counts
of subtypes of monocytes and of lymphocytes were determined
after staining with monoclonal antibodies and analysis by flow
cytometry. Peripheral blood mononuclear cells (PBMCs) were
isolated and stimulated with various bacterial stimuli. Concen-
trations of TNFα, of IL-1β and of IFNγ were estimated in super-
natants by an enzyme immunoassay.
Results  Mean absolute counts of CD14 monocytes of healthy
volunteers, of FLS and of patients infected by the H1N1 virus were
271.1, 464.4 and 607.2%, respectively (P  <0.0001 compared
with other groups). Respective values of CD4+/CD25+/CD127–
cells were 2.0, 4.7 and 9.0% (P <0.0001 compared with other
groups). Respective values of CD19 cells were 297.9, 151 and
137.9%. No differences between the three groups were found
regarding CD3/CD4 lymphocytes, CD3/CD8 lymphocytes, natural
killer (NK) cells and NKT cells. No differences were also found
regarding the rate of apoptosis of the above subtypes. Six patients
had H1N1-related pneumonia. Mean T-regulatory cells (Tregs) of
H1N1-infected patients without pneumonia and with pneumonia
were 6.7 and 17.8%, respectively (P = 0.034). Mean release of
TNFα by phytohemagglutin-stimulated PBMCs of healthy
volunteers, of FLS and of patients infected by H1N1 was 3,658.5,
1,877.3 and 874.4 pg/ml, respectively (P <0.0001 compared with
other groups). Respective release of TNFα by  Streptococcus
pneumoniae-stimulated PBMCs was 1,836.9, 949.9 and
478.0 pg/ml (P  <0.0001 compared with other groups). Mean
respective release of IFNγ by PHA-stimulated PBMCs was
1,651.8, 1,235.1 and 1,114.3 pg/ml (P = 0.010 compared with
FLS). Mean respective release of IFNγ by S. pneumoniae-stimu-
lated PBMCs was 1,085.7, 748.1 and 709.7 pg/ml (P = 0.024
compared with FLS). No effect of other stimuli was shown on
release of TNFα and of IFNγ. Release of IL-1β was not affected.
Conclusions  Infection by the H1N1 virus is accompanied by a
characteristic impairment of the innate immune responses charac-
terized by defective cytokine responses to S. pneumoniae.
Alterations of the adaptive immune responses are predominated by
an increase of Tregs. These findings signify a predisposition for
pneumococcal infections after infection by H1N1 influenza.
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Introduction In a recently published double-blind, randomized trial
conducted by our study group, clarithromycin was intravenously
administered in patients with ventilator-associated pneumonia
(VAP) and sepsis for three consecutive days [1]. An earlier
resolution of VAP and a fivefold decrease of the risk for death by
septic shock and multiple organ failure (MODS) compared with
placebo were shown.
Objective To investigate the mode of action of clarithromycin.
Methods  Blood was sampled before administration of the
investigational product and on six consecutive days. Peripheral
blood mononuclear cells (PBMCs) were isolated after gradient
centrifugation over Ficoll. PBMCs were incubated and adherent
monocytes were harvested and stimulated for 24 hours with
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Figure 1 (abstract P25)
*Statistically significant differences between groups at the indicated time intervals. Day 0 corresponds to time before start of the investigational
drug.S12
10 ng/ml LPS of Escherichia coli O55:B5. Concentrations of
TNFα and of IL-6 were estimated in supernatants by an enzyme
immunoassay.
Results  One hundred patients were treated with placebo and
another 100 patients with clarithromycin. Median concentrations of
TNFα and of IL-6 in monocyte supernatants of all patients and
separately of those with septic shock and MODS are shown in
Figure 1.
Conclusions Administration of clarithromycin was accompanied by
a considerable improvement of the response of monocytes to ex
vivo stimulation with the release of TNFα and IL-6. These results
signify that clarithromycin effectively reverses sepsis-induced
immunoparalysis of monocytes.
References
1. Giamarellos-Bourboulis EJ, Pechère JC, Routsi C, et al.:
Effect of clarithromycin in patients with sepsis and ventila-
tor-associated pneumonia. Clin Infect Dis 2008, 46:1157-
1164.
P26
Plasma-derived human antithrombin attenuates ventilator-
induced coagulopathy in a Streptococcus pneumoniae
pneumonia model in rats
H Aslami1,2, JJ Haitsma1, JJ Hoffstra2, M Levi2, H Zhang1, 
AS Slutsky1, MJ Schultz1
1Interdepartmental Division of Critical Care Medicine, Keenan
Research Center, Li Ka Shing Knowledge Institute, St Michael’s
Hospital, Toronto, Ontario, Canada; 2Departments of Intensive Care
and Internal Medicine, Laboratory of Experimental Intensive Care
and Anesthesiology, Academic Medical Center, University of
Amsterdam, the Netherlands
Critical Care 2009, 13(Suppl 4):P26 (doi: 10.1186/cc8082)
Introduction  Pneumonia is characterized by local activation of
coagulation leading to alveolar fibrin deposition. Lung injurious
mechanical ventilation (LI-MV) with conventional tidal volumes (VT)
and no positive end-expiratory pressure (PEEP) aggravates
pulmonary coagulopathy. We hypothesized administration of anti-
thrombin (AT), a natural anticoagulant, to attenuate ventilator-
induced coagulopathy and inflammation in a rat model of Strepto-
coccus pneumoniae pneumonia.
Methods  Rats challenged intratracheally with bacteria were
ventilated 40 hours later (VT = 12 ml/kg/no PEEP) after systemic
administration of plasma-derived human AT (250 U/kg) or placebo
for 3 hours. Endpoints: BALF levels of thrombin–antithrombin
complexes (TATc), fibrin degradation products (FDP), AT,
plasminogen activator activity (PAA), plasminogen activator
inhibitor-1 (PAI-1), pulmonary cytokines and blood cultures. Data
are presented as the mean ± SD. Statistics: one-way ANOVA with
Dunn’s multiple comparison test.
Results  S. pneumoniae pneumonia was characterized by
activation of coagulation (TATc: in pneumonia vs. healthy control,
3.7 ± 0.3 vs. 1.2 ± 0.5 ng/ml; FDP: 291 ± 40 vs. 15 ± 5 ng/ml;
AT: 3.7 ± 0.3 vs. 20.0 ± 5.2 IU/ml – all P <0.05) and inhibition of
fibrinolysis (PAA: 99.2 ± 5.9 vs. 73.3 ± 5.7% of normal, P <0.05;
PAI-1: 1.9 ± 0.6 vs. 10.0 ± 1.4 ng/ml, P <0.05). Systemic
administration of AT resulted in supraphysiologic levels of BALF AT
levels (25.4 ± 4.9 vs. 5.3 ± 1.0 IU/ml) and prevented further
activation of coagulation by MV (TATc: in LI-MV with AT vs.
placebo, 3.9 ± 0.3 vs. 6.5 ± 0.8 ng/ml – P <0.05). No changes in
pulmonary cytokines were observed between the infected and
mechanically ventilated animals (TNF: LI-MV with AT vs. placebo,
1.6 ± 0.4 vs. 1.9 ± 1.3 ng/ml and IL-6: 2.5 ± 1.3 vs. 2.4 ± 1.4 ng/ml
–  P = NS). The infected animals showed similar numbers of
bacteria in blood samples at the start of the experiment, which did
not change during the experiment.
Conclusions Systemic administration of AT attenuated ventilator-
induced coagulopathy but not inflammation.
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Introduction  Streptococcus pneumoniae is the most common
causative pathogen in community-acquired pneumonia and a major
cause of sepsis. Pneumonia elicits a procoagulant state in the lung
resulting from activation of coagulation, downregulation of
anticoagulant pathways and concurrent inhibition of fibrinolysis.
Tissue factor is the main initiator of coagulation. Recombinant
human tissue factor pathway inhibitor (rh-TFPI) attenuates sepsis-
induced coagulation and has been evaluated in clinical trials
involving patients with sepsis and community-acquired pneumonia.
Objective  To examine the effect of rh-TFPI on coagulation,
inflammation and bacterial outgrowth in S. pneumoniae pneumonia
in mice, either alone or with concurrent antibiotic treatment.
Methods Pneumonia was induced by intranasal inoculation with S.
pneumoniae. Four groups of mice (n = 8) were treated intra-
peritoneally with (1) placebo, (2) rh-TFPI every 8 hours, (3)
ceftriaxone twice daily or (4) rh-TFPI in combination with
ceftriaxone. Early (8 hours) and late (24 hours) initiated treatments
were evaluated. Bronchoalveolar lavage fluid (BALF), lungs and
plasma were obtained 24 hours (for groups in which treatment was
started after 8 hours) or 48 hours (treatment started after 24 hours)
after infection. Statistical analysis was performed by Mann–Whitney
U test.
Results  Pneumonia resulted in local and systemic activation of
coagulation (as reflected by increased thrombin–antithrombin
complexes) and inhibition of fibrinolysis (as reflected by increased
plasminogen activator inhibitor-1 and decreased plasminogen
activator activity). Both early and late treatment with rh-TFPI
reduced pneumonia-induced coagulation in lungs and plasma; rh-
TFPI given with ceftriaxone further attenuated coagulation relative
to ceftriaxone only. No effects of rh-TFPI on pneumonia-inhibited
fibrinolysis were observed. Cell recruitment in BALF did not differ
between groups. Remarkably, rh-TFPI reduced levels of several
cytokines and chemokines not only in lung homogenates, but also
in BALF (IL-6, IFNγ, MCP-1, LIX) and plasma (IL-6, TNFα, IFNγ).
The attenuated host inflammatory response was not reflected by
differences in total histopathology scores between treatment
groups. In mice not treated with ceftriaxone, rh-TFPI decreased
bacterial loads in lung homogenates ~10-fold (P  <0.01 vs.
placebo) at 48 hours, while leaving bacterial loads in BALF and the
systemic compartment unaltered.
Conclusions rh-TFPI attenuates local and systemic coagulopathy,
the local and systemic inflammatory response and pulmonary
bacterial growth during S. pneumoniae pneumonia in mice.
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Introduction  Invasive candidiasis is a severe systemic fungal
infection with Candida spp. affecting immunocompromised hosts,
which is responsible for the highest mortality rate of all nosocomial
infections. Although several clinical predisposing factors are
known, the individual risk for developing invasive candidiasis varies
significantly. Recognition of fungi such as Candida albicans is
mediated through receptors of the innate immune system, such as
Toll-like receptors (TLRs), that in turn activate innate immune
system and antifungal defense.
Objective To assess whether polymorphisms in fungal innate immune
receptors such as TLRs and dectin-1 influence susceptibility to
invasive candidiasis.
Methods Frequencies of mostly nonsynonymous polymorphisms in
several innate immune receptors were genotyped in a total of 331
patients that developed invasive candidiasis and compared with a
total of 341 matched control patients that had the same
predisposing factors. These included neutropenia, mucosal barrier
injury and treatment with immunosuppressive regimens. Further-
more, in vitro studies with healthy volunteers were conducted to
assess the functional consequences of these polymorphisms
regarding cytokine responses.
Results Genotyping for polymorphisms in innate immune receptor
genes revealed a higher frequency of three independent non-
synonymous TLR1 polymorphisms in the affected group patients
that developed invasive candidiasis. These polymorphisms were
also demonstrated to be associated with impaired cytokine
responses upon stimulations of immune cells, including IL-1β, IL-6
and IL-8.
Conclusions Polymorphisms in TLR1, which is known to dimerize
with TLR2 and TLR6, are associated with impaired immune
recognition through these receptors and predispose to invasive
candidiasis in humans.
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Introduction International surviving sepsis guidelines identified an
important role for acute medicine in early management of severe
sepsis, but local and multicentre international audits show poor
adherence to these guidelines.
Materials We evaluated the use of a Sepsis Case Record (SCR)
supported by a systematic educational programme to improve
standards. A one-page SCR was derived from surviving sepsis
guidelines, to prompt recognition of sepsis syndromes, compre-
hensive secondary assessment, initiation of resuscitation and
antibiotic treatment bundles, and appropriate specialist consulta-
tions. The SCR was introduced in the emergency and acute
assessment units in our teaching hospital setting within central
London, accompanied by a seminar-based educational programme
for medical and nursing staff.
Methods Two months after its introduction, the use of the SCR
form was audited in all acute medical admissions who met the
clinical criteria for sepsis. One hundred sequential patients were
assessed in a 6-week period over the winter.
Results One-half of the audit sample had SCR forms completed.
Specificity of the sepsis criteria was good, with <10% of patients
subsequently judged not to have had sepsis. The patients with and
without audit forms had comparable demographics, severity of
illness and microbiology (Figure 1). Frequency of abnormal
temperature was significantly higher in patients with the SCR,
suggesting fever remains an important prompt for physicians to
consider sepsis. The use of the SCR was also associated with
significantly improved assessment of GCS, lactate, travel history
and the need for isolation, as well as significantly greater number of
specialist consultations (Table 1), albeit still inadequate, ~10%
(without SCR) to ~20% (with SCR). The SCR had no effect on
frequency of clinical review by senior resident physicians,
recording of FiO2, antibiotic guidelines compliance or blood/urine
culture requests, all evident in 40 to 60% of patients. Approxi-
mately 75% of all patients received antibiotics within 2 to 6 hours,
and a trend for earlier antibiotics was associated with use of the
SCR (Figure 2).
Conclusions  The SCR was well received but not used
consistently. The lack of abnormal temperature may contribute to
this. The use of the SCR did improve early management of sepsis,
Available online http://ccforum.com/supplements/13/S4
Figure 1 (abstract P29)S14
but a number of deficiencies persisted. Implementation of sepsis
guidelines remains a major challenge in clinical practice. Succinct
guidelines were helpful in this setting but need additional
educational and feedback support to improve standards of practice.
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Introduction  The role of the IL-17 pathway in fungal sepsis
remains controversial. Several studies suggested that IL-17 is
crucial for the protection against Candida sepsis, while other
studies reported that IL-17 may contribute to inflammatory
pathology and worsening of fungal disease. To address these
discrepancies, we assessed the differential role of IL-17 pathway in
two models of fungal sepsis: intravenous infection with live
Candida albicans, in which fungal growth is the main cause of
mortality, and zymosan-induced multiple organ failure in which the
inflammatory pathology drives the mortality.
Methods  IL-17 receptor-deficient (IL-17RA–/–) and control mice
were intravenously infected with 2 x 105 CFU live C. albicans
UC820 per mouse. Mortality, fungal loads in the kidneys,
neutrophil recruitment and phagocytosis and killing were assessed.
IL-17RA–/– and control mice were also assessed for mortality in a
multiorgan failure sepsis model induced by the fungal component
zymosan.
Results  On the one hand, IL-17RA–/– mice showed increased
mortality and higher fungal loads in the kidneys in the model of
disseminated candidiasis. On the other hand, the absence of
IL-17RA in the knockout mice did not protect the mice against the
multiorgan failure induced by zymosan. Furthermore, no reduction
in neutrophil recruitment and defects in phagocytosis and killing in
the first few hours of Candida infection were found. A significantly
lower TNF production in response to Candida in cells from
IL-17RA–/– mice was observed.
Conclusions These data demonstrate that the IL-17 pathway does
not have a major contribution to the inflammatory pathology leading
to organ failure in fungal sepsis, and support the concept that the
IL-17 pathway is protective during fungal sepsis. In addition, IL-17
deficiency does not appear to reflect a pure innate defect, since it
did not result in loss of neutrophil recruitment and function during
the first few hours of fungal sepsis. Furthermore, the lower TNF
production in response to Candida in cells from IL-17RA–/– mice
could contribute to susceptibility to disseminated candidiasis.
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Introduction IL-1β plays an important role in antifungal defense.
The inflammasome is thought to be required for caspase-1
activation and processing of the inactive precursor pro-IL-1β into
its active form. Contradictory data have been reported regarding
the role of the inflammasome in Candida sepsis. In order to
address these discrepancies, we investigated host defense against
disseminated candidiasis in knockout mice defective in the various
components of the inflammasome.
Methods Mice defective in caspase-1, ASC, NLRP3 or P2X7 were
infected intravenously with Candida albicans. Survival, fungal
outgrowth in the organs, histology, and cytokine production were
compared in these mouse strains with the wild-type C57/Bl6
control mice. PBMCs from healthy volunteers with or without
reactive oxygen species (ROS) inhibitor and PBMCs from patients
with chronic granulomatous disease (CGD) that are deficient in
ROS production were stimulated with C. albicans.
Results  Caspase-1–/– mice and ASC–/– mice had a decreased
survival during disseminated candidiasis (50%) compared with the
control mice (100%). Caspase-1–/– mice had a 100-fold increase
in fungal loads in the kidneys of the deficient animals (P <0.05)
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Table 1 (abstract P29)
Parameter With Forms No Forms P value
SpR review 24/50 25/50 ns
FiO2 29/50 25/50 ns
Blood culture 42/50 35/50 ns
Urine culture 29/50 23/50 ns
Abx guide compliant 31/50 25/50 ns
ID consult 9/50 8/50 ns
ITU consult 11/50 6/50 ns
GCS 40/50 29/50 <0.05
Lactate 45/50 35/50 <0.05
Micro consult 6/50 0/50 <0.05
Any consult 20/50 8/50 <0.05
Travel history 23/50 9/50 <0.05
Need for isolation 18/50 2/50 <0.05
ns, not significant.
Figure 2 (abstract P29)S15
and histological assessment revealed preferential growth of
hyphae in the pyelum of the caspase-1–/– mice. In contrast, ASC–/–
mice did not have higher fungal loads, but they showed a
significant stronger inflammatory reaction in the kidneys. On days 3
and 7 of infection, the ASC–/– mice splenocytes that were
restimulated with Candida specifically showed a higher TNF
production. NLRP3–/– and P2X7–/– did not display an increased
susceptibility to disseminated candidiasis, as shown by normal
survival and fungal loads in the organs. Local IL-1β production was
lower in caspase-1–/– mice, but not in the ASC–/–, NLRP3–/– or
P2X7–/– animals. Experiments using the NADPH inhibitor diphenyl-
eneiodonium, or in monocytes isolated from CGD patients who
have defective capacity to form ROS, demonstrated that ROS did
not mediate inflammasome activation and C. albicans induced
IL-1β production.
Conclusions  Caspase-1-dependent processing of IL-1β is an
important step in antifungal host defense during Candida sepsis.
However, this process is not dependent on the inflammasome
components NLRP3, the ATP receptor P2X7, or ROS. These data
confirm previous studies in human monocytes showing that IL-1β
processing during Candida infection did not require pathogen-
mediated inflammasome activation, due to the constitutive activation
of caspase-1. ASC also plays an important role in Candida sepsis,
but unexpectedly seems to have a different function, specifically by
regulating TNF production and local inflammation in the organs.
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Introduction Mortality associated with severe sepsis remains high
at 30 to 50% and rises to 50 to 60% when shock is present. The
Surviving Sepsis Campaign (SSC) recommends two bundles for
severe sepsis management to achieve 25% reduction in mortality;
the Initial Resuscitation Bundle (within the first 6 hours) and the
Management Bundle (within 24 hours). West Middlesex University
Hospital set up a severe sepsis management protocol based on the
SSC initial resuscitation and management bundles. It is a 350-bed
hospital with an emergency department. Five hundred patients
(medical and surgical) are admitted to the critical care unit per year.
Objective  To assess the early recognition of sepsis and the
application of the initial resuscitation bundle according to SSC
guidelines at West Middlesex University Hospital.
Methods Retrospective data collection of all patients with severe
sepsis or septic shock who were admitted to the ITU over 3 months
(December 2008, January and February 2009). All patients who
developed sepsis before admission to the ITU/HDU were included.
Results  Thirty-three patients were admitted to the ITU at West
Middlesex Hospital with either severe sepsis or septic shock.
Median age was 72 years. The overall mortality rate was 50%.
Patients with septic shock had a mortality rate of 52%. The results
of the initial resuscitation of the patients are summarized in Table 1.
In septic shock patients, only 35% had ITU intervention within 6
hours (had CVP insertion and/or started on vasopressor and/or
inotropic support). Central venous oxygen saturation or mixed
venous oxygen saturation was not measured for these patients.
Conclusions  Early recognition and the initial resuscitation of
sepsis at this District General Hospital were assessed for the first
time. Patients with severe sepsis or septic shock were not
resuscitated appropriately and the SSC guidelines were not
implemented, resulting in a high mortality rate. The results showed
that there is a delay in recognizing sepsis at early stages resulting
in inadequate management of patients. In septic shock patients,
this resulted in delayed CVP measurement and administration of
vasopressors and/or inotropic support. Therefore, we have
suggested an educational programme running throughout the year
to educate medical and nursing teams about the early recognition
and management of sepsis, with emphasis on the strict
implementation of all tasks of sepsis protocol according to SSC
guidelines to reduce the mortality rate by 25%. We also suggest
setting up critical care beds on each ward that will be supported
by ITU outreach for CVP insertion and level 1 monitoring.
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Introduction  The mixed V1a/V2 receptor agonist arginine vaso-
pressin (AVP) is recommended by the guidelines of the Surviving
Sepsis Campaign as an adjunct vasopressor in norepinephrine-
resistant septic shock. However, AVP may be procoagulant
Available online http://ccforum.com/supplements/13/S4
Table 1 (abstract P32)
Breakdown of tasks of the initial resuscitation bundle achieved within 6 hours
% of patients 
Number of patients  where SSC 
achieved/total number  recommendation 
Initial resuscitation tasks (within 6 hours) of patients was followed
Serum lactate measured 25/33 76
Obtaining blood cultures prior to antibiotic administration 6/33 18
Broad-spectrum antibiotics within 3 hours from time of presentation for Emergency Department admissions 6/9 67
1 hour for non-Emergency Department ICU admissions 5/24 21
In patients with septic shock or serum lactate >4 mmol/l (36 mg/dl)
Fluid challenges 7/23 30
Vasopressors 17/23 74
CVP >8 mmHg in nonmechanically ventilated patients (12 to 15 in mechanically ventilated patients) 2/23 9S16
through V2 receptor-mediated effects (for example, von Willebrand
factor (vWF) release).
Objective We hypothesized that the selective V1a receptor agonist
FE 202158, which lacks the activity at the V2 receptor, might not
have the procoagulant effects of AVP. This hypothesis was tested
by measuring vWF antigen (vWF:Ag) activity in plasma of healthy
sheep during administration of either FE 202158, AVP, the
selective V2 receptor agonist desmopressin, or vehicle.
Methods After measurements of vWF:Ag activity and hemoglobin
concentration in blood over a 1-hour baseline period, 24 female
sheep were randomly assigned to receive either an intravenous
bolus of the selective V2 receptor agonist desmopressin (1 nmol/kg)
or a continuous intravenous infusion of AVP (3 pmol/kg/min), the
selective V1a receptor agonist FE 202158 (10 pmol/kg/min) or
vehicle (0.9% NaCl, n = 6 each). The infusion rates were represen-
tative of the requirements for the treatment of sepsis-induced
vasodilatory hypotension in sheep. vWF:Ag activity and hemo-
globin concentration were measured 60, 90 and 120 minutes after
initiation of treatment. Because of the V2 receptor-mediated fluid
retention, vWF:Ag activity was corrected for plasma volume
changes by calculating the ratio of vWF:Ag activity/hemoglobin
concentration (vWF:Ag/Hb). Data are expressed as a percentage
of the mean baseline value and presented as mean ± SEM.
Results  Whereas there were no significant changes in
vWF:Ag/Hb in vehicle-treated animals over time, desmopressin
and AVP caused an immediate increase in vWF:Ag/Hb after
60 minutes (129 ± 6% and 121 ± 2% of baseline (100%), respec-
tively; P <0.01 each). At each time point during the 120-minute
study period, vWF:Ag/Hb was significantly higher in desmo-
pressin-treated and AVP-treated animals than in vehicle-treated
animals (P  <0.001 each). In contrast, there was no significant
difference between FE 202158-treated and vehicle-treated
animals (P = 0.225). Notably, vWF:Ag/Hb in the FE 202158 group
(maximum 108 ± 2% at 120 minutes) was significantly lower than
the AVP group (maximum 123 ± 2% at 60 minutes; P ≤0.005) and
the desmopressin group (maximum 138 ± 6% at 120 minutes;
P <0.001) at every time point.
Conclusions  Unlike AVP, the selective V1a receptor agonist FE
202158 did not increase vWF:Ag/Hb ratios in plasma compared
with vehicle-treated animals. Therefore, a selective V1a receptor
agonist such as FE 202158 might be superior to AVP or other
mixed V1a/V2 receptor agonists under conditions that produce
activation of the coagulation system, such as severe sepsis and
septic shock.
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Introduction  More than 750,000 patients in the United States
develop sepsis annually. Previously, we have shown that plasma
nitric oxide (NO) levels were approximately sevenfold higher and
that arginase activity is significantly lower in methicillin-resistant
Staphylococcus aureus (MRSA) sepsis than in Pseudomonas
aeruginosa sepsis. In the present study, we hypothesize that
increased asymmetrical dimethyl-arginine (ADMA), an endogenous
inhibitor of NO synthase, is responsible for the suppressed NO
production in Ps. aeruginosa sepsis.
Methods Ewes were operatively prepared and randomized after a
7-day recovery period into control, MRSA, and Ps. aeruginosa
groups (n = 6). Injury consisted of instillation of (2 to 5) x 1011 CFU
live MRSA or Ps. aeruginosa into the airway, and the sheep were
sacrificed after 24 hours. In addition, groups of C57Bl/6J wild-type
mice and iNOS knockout mice (n = 6) were nasally inoculated with
(2 to 5) x 108 CFU live MRSA or Ps. aeruginosa and were
sacrificed after 8 hours.
Results Ps. aeruginosa-treated sheep had a significantly higher
ADMA (1.79 ± 0.14 vs. 1.16 ± 0.24 μM, P <0.05), lower plasma
NOx (6.83 ± 0.17 vs. 9.63 ± 0.64 μM,  P  <0.05), and higher
arginase activity (1.55 ± 0.16 vs. 1.07 ± 0.11 μM urea/μg protein,
P  <0.05) compared with MRSA-treated sheep. These changes
were associated with more pronounced lung injury in Ps. aerugi-
nosa sepsis compared with MRSA sepsis (PaO2/FiO2: 205 ± 72
vs. 319 ± 82, P <0.05). Ps. aeruginosa-treated mice had a signifi-
cantly higher arginase activity (0.60 ± 0.12 vs. 0.16 ± 0.0038 μM
urea/μg protein, P  <0.05) and higher protein oxidation with
carbonyl groups (3,223 ± 440.7 vs. 1,124 ± 140.1, P  <0.05)
compared with MRSA-treated mice. iNOS knockout mice treated
with MRSA had significantly lower arginase activity than wild-type
mice (0.21 ± 0.01 vs. 0.36 ± 0.04 μM urea/μg protein, P <0.05).
Conclusions Suppressed NO production in Ps. aeruginosa sepsis
is caused by the increased expression of ADMA. Increased
arginase activity is most probably caused by augmented oxidative
stress, which results in a more severe lung injury.
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Introduction  The exact pathogenic role of disseminated intra-
vascular coagulation (DIC) during septic shock is incompletely
understood.
Objective We studied the relation between sensitive and specific
markers for DIC and lactate levels in the course of time, to evaluate
whether DIC could contribute to microvascular obstruction and
tissue hypoxygenation.
Methods We prospectively studied 14 consecutive septic shock
patients with a pulmonary artery catheter in place. For 3 days after
admission, hemodynamic variables, and plasma levels of lactate,
thrombin–antithrombin complexes (TAT), tissue plasminogen
activator (tPA), plasminogen activator inhibitor (PAI) and plasmin–
α2-antiplasmin complexes and TNFα, IL-6 and complement
activation product C3a were measured 6-hourly.
Results Of the 14 patients, eight died in the ICU. Patients had a
hyperdynamic circulation with tachycardia, mild hypotension and
increased cardiac index. The course of TAT, tPA and particularly of
PAI predicted the course of lactate levels, independently of
hemodynamic and inflammatory factors. Lactate and PAI elevations
persisted in nonsurvivors versus survivors.
Conclusions Our observations show that, in the course of human
septic shock, activation of coagulation and, particularly, inhibition
of activated fibrinolysis are independently associated with
hyperlactatemia. This suggests a contribution of DIC resulting from
a coagulation/fibrinolysis imbalance to microvascular obstruction,
tissue hypoxygenation and thereby to ultimate demise.
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Introduction Procalcitonin (PCT) and IL-6 are markers used in the
evaluation of systemic inflammation (SIRS) and septic states. The
purpose of this study is to analyse changes in plasma concen-
trations of PCT and IL-6 in patients undergoing cardiac surgery on-
pump and assess its reliability in the early detection of post-
operative infectious complications. In all patients the variation of
brain natriuretic peptide (BNP) was also evaluated in order to
stratify the clinical condition of patients.
Methods  We measured serum levels of PCT, IL-6 and BNP in
adult patients undergoing myocardial revascularization and/or valve
surgery performed in extracorporeal circulation. The measurements
were performed on the day before the intervention (T0), at the end
of surgery (T1) and then until the third and fourth postoperative day
(T2 to T4). We also recorded the onset of cardiac, respiratory,
neurological, renal and septic complications. The diagnosis of
sepsis was confirmed retrospectively on the basis of clinical,
radiological and microbiological data. All data are expressed as
mean and standard deviation. The Kruskal–Wallis test was used to
assess changes over time of variables. P <0.05 was considered
statistically significant.
Results There have been enrolled 60 patients undergoing cardiac
surgery in extracorporeal circulation. Among these, nine patients
developed septic complications. The results of temporal changes
and the significance are presented in Table 1.
Table 1 (abstract P36)
Results of temporal changes and significance
T0 T1 T2 T3 T4
PCT (ng/ml)
Nonseptic 0.04 0.04 0.58 0.34 0.34
Septic 0.04 0.15 2.63 1.87 0.74
P NS <0.001 <0.001 <0.001 <0.01
IL-6 (pg/ml)
Nonseptic 12 160 129 78 75
Septic 18 184 145 261 92
P NS NS NS <0.01 NS
BNP
Nonseptic 159 154 347 428 492
Septic 373 627 731 756 798
P <0.01 < 0.01 <0.01 <0.05 <0.05
Conclusions  In patients who develop septic complications,
changes in PCT occur earlier than changes in IL-6. Furthermore,
BNP performs in the same fashion as PCT and correlates better
than IL-6 with the clinical data of the infection status. In conclusion,
monitoring PCT seems to be useful in early diagnosis of septic
complications in patients undergoing cardiac surgery and more
sensitive on the variations in IL-6. The combined study of variations
in PCT and BNP could improve the diagnostic accuracy in these
patients.
P37
T-cell-specific peroxisome proliferator-activated receptor
gamma depletion inhibits T-cell apoptosis and improves
survival of septic mice via an IL-2-dependent mechanism
MV Schmidt1, P Paulus2, A-M Kuhn1, V Meilladec-Jullig1, 
K Zacharowski2, B Bruene1, A von Knethen1
1Institute of Biochemistry I, Faculty of Medicine, Goethe-University
Frankfurt, Germany; 2Department of Anaesthesia, Intensive Care
Medicine & Pain Therapy, University Hospital Frankfurt, Germany
Critical Care 2009, 13(Suppl 4):P37 (doi: 10.1186/cc8093)
Introduction Immune paralysis with massive T-cell apoptosis is a
central pathogenic event during sepsis and correlates with septic
patient mortality. Previous observations implied a crucial role of
peroxisome proliferator-activated receptor gamma (PPARγ) during
T-cell apoptosis.
Methods  To elucidate mechanisms of PPARγ-induced T-cell
depletion, we used an endotoxin model as well as the caecal
ligation and puncture sepsis model to imitate septic conditions in
wild-type versus conditional PPARγ knockout (KO) mice.
Results  PPARγ KO mice showed a marked survival advantage
compared with control mice. Their T cells were substantially
protected against sepsis-induced death and showed a significantly
higher expression of the pro-survival factor IL-2. Since PPARγ is
described to repress nuclear factor of activated T cells (NFAT)
transactivation and concomitant IL-2 expression, we propose
inhibition of NFAT as the underlying mechanism allowing T-cell
apoptosis. Corroborating our hypothesis, we observed up-
regulation of the pro-apoptotic protein BIM and downregulation of
the anti-apoptotic protein Bcl-2 in control mice, which are down-
stream effector proteins of IL-2 receptor signaling. Application of a
neutralizing anti-IL-2 antibody reversed the pro-survival effect of
PPARγ-deficient T cells and confirmed IL-2-dependent apoptosis
during sepsis.
Conclusions  Apparently antagonizing PPARγ in T cells might
improve their survival during sepsis, which concomitantly enhances
defence mechanisms and possibly provokes an increased survival
of septic patients.
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Introduction  Organ dysfunction is an integrated part of severe
sepsis, and severe sepsis is one of the major causes of death in
ICUs. Lately Gram-positive bacteria accounted for more than one-
half of the overall sepsis cases reported in the USA, with
Staphylococcus aureus being the most commonly isolated
bacterium. Effective treatment of sepsis is still not optimal and
good animal models are needed for research in pathogenesis and
treatment. S. aureus infections are also common in pigs and are
isolated from approximately 40% of embolic lesions found in
slaughter-pigs.
Objective To establish a porcine model of severe sepsis.
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Methods Twelve pigs in four groups were inoculated intravenously
once or twice with 1 x 108 S. aureus/kg body weight and eutha-
nized consecutively from 6 to 48 hours after inoculation. Mock-
inoculated pigs served as controls. Body temperature was
measured and blood samples were taken at regular intervals for
bacteriology, haematology, clinical chemistry, and acute phase
reactant determinations. Full necropsy was done and tissue
samples were collected for bacteriology and histology. Apoptosis
was measured in the spleen.
Results Onset of clinical disease (fever and lethargy) was seen at
7 to 8 hours after inoculation. Blood bacterial counts remained low
throughout the study. SIRS characterized by fever, leukocytosis,
increased levels of CRP, IL-6, IL-1β, TNFα, and decreased level of
serum iron was detected after 12 hours. Both CRP and IL-6 levels
peaked at 36 hours. Platelet numbers declined slightly and were
lower than in the controls at 48 hours. Thromboelastography
showed increased hypercoagulability over time. Levels of serum
aspartate aminotransferase and bilirubin were elevated at 24 and
36 hours. Blood urea nitrogen levels had increased at 36 hours;
however, no difference was seen in serum creatinine levels.
Disseminated microabscesses were found in the lung at 6 hours,
but had disappeared at 48 hours. In the bones, the presence of
microabscesses progressed until 48 hours. Other histopatho-
logical signs related to inoculation were limited to a renal
microabscess at 12 hours, splenic microabscesses at 24 hours
and centrilobular hepatic necrosis with thrombosis in one animal at
48 hours. In the liver and kidneys, various degrees of fibrinous
exudation were found. The number of apoptotic cells in the splenic
white pulp was increased at 48 hours.
Conclusions All infected pigs developed sepsis with metastatic
abscesses and at 48 hours severe sepsis was present with signs
of dysfunction of the liver and the coagulation system. The splenic
apoptotic response indicates reduced function and immuno-
suppression.
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Introduction  Streptoccocus pneumoniae pneumonia remains
associated with high morbidity and mortality. Antibiotic treatment
frequently is insufficient in limiting lung damage due to inflam-
mation. Therefore, additional treatment strategies are needed. The
drug r-roscovitine, a cyclin-dependent kinase (CDK) inhibitor, was
demonstrated to reduce inflammation in several models of
inflammation.
Objective We studied the potential of r-roscovitine to modulate
host defense during sterile inflammation and bacterial infection of
the lung.
Methods Isolated neutrophils were treated with 20 μM r-roscovitine
and CDK and caspase 3 activity were determined by western blot
analysis. Sterile lung inflammation was induced by intranasal
administration of 100 μg lipoteichoic acid (LTA), a prominent cell
wall component of Gram-positive bacteria. Simultaneously
70 mg/kg r-roscovitine or vehicle was injected intraperitoneally.
Twenty-four hours later bronchoalveolar lavage (BAL) was
performed and differential cell counts were determined. Bacterial
pneumonia was induced by inoculation of 5 x 104 CFU  S.
pneumoniae. r-Roscovitine (70 mg/kg) or vehicle was administered
24 hours later in combination with antibiotic therapy (ceftriaxon;
20 mg/kg). Mice were sacrificed after 48 hours. In a second
experiment, mice were infected and treated at 24 and 72 hours
and sacrificed 96 hours post infection.
Results r-Roscovitine treatment significantly reduced phosphory-
lated CDK substrate and increased cleaved caspase 3 levels in
isolated neutrophils. During LTA-induced lung inflammation,
r-roscovitine treatment significantly reduced the amount of PMNs
in the BAL fluid and cytokines in lung homogenates. After 48 hours
of bacterial pneumonia, r-roscovitine-treated animals displayed
enhanced pulmonary bacterial outgrowth. Cytokine production and
lung damage scores were higher in the r-roscovitine-treated group
as compared with vehicle. Interestingly, when studying the animals
at 96 hours post infection, r-roscovitine treatment resulted in lower
bacterial outgrowth and chemokine levels in the lung.
Conclusions With this study, we reproduced earlier findings that
r-roscovitine treatment reduces CDK activity and induces
apoptosis in neutrophils; we demonstrated that r-roscovitine
diminishes inflammatory responses in sterile inflammation; and we
found that r-roscovitine treatment in bacterial pneumonia is
detrimental early in infection but beneficial at later time points. We
believe that the negative effect of r-roscovitine reflects the
importance of neutrophil antibacterial defense early in infection.
Yet, during resolution of infection, apoptosis of neutrophils induced
by r-roscovitine could present a way of damage control as
opposed to unwanted side effects of neutrophil function.
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Introduction Malaysian honey (Gelam) has antibacterial activity and
it also has a high antioxidant capacity and free radical scavenger
activities. Honey extracts showed potent activity against TNFα in
L929 cell and NO in RAW 264.7 macrophage as well as inhibitory
effects on the prostaglandin E2 and nitric oxide (NO) in inflammatory
tissues of rat. Sepsis is mediated in part by bacterial endotoxin,
which stimulates macrophages/monocytes to sequentially release
early (for example, TNF, IL-1) cytokines and inducible enzymes such
as inducible nitric oxide (iNOS) synthase and heme oxygenase 1
(HO-1) and late such as high-mobility group box 1 (HMGB1).
Objective To investigate the role of honey as an immunomodulator
in sepsis induced by LPS in rats.
Methods Four groups (n = 6) of rats were used. The treatment
group received honey with LPS, the positive control group were
given LPS (5 mg/kg), the negative control group were given saline
only, while the fourth group were only given honey; all doses were
1 ml by intravenous route. Blood samples were collected 4 hours
later and all rats were sacrificed after 24 hours. TNFα, IL-1β, IL-6,
IL-10, NO, HO-1 and HMGB1 were quantified using ELISA. The
effect of honey on coagulation (PT and APPT) in whole blood ex
vivo from healthy volunteers (n = 10) was measured.
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Results After 4 hours of treatment, the cytokines, NO and HO-1
were measured in all groups. Honey showed evidence of immuno-
modulatory effects with reduced cytokines (TNFα (P < 0.001),
IL-1β (P < 0.001), IL-10 (P < 0.001)) and NO (P < 0.037) in the
treatment group, while the change in IL-6 was not significant
between all groups, HO-1 (P < 0.001) was increased in the
treatment group, but only slightly increased in the honey group.
After 24 hours of treatment, HMGB1 (P <0.025) and IL-1β
(P <0.001) were reduced in the treatment group as well. HO-1
(P <0.013) continuously increased in all groups. Curiously, honey
alone induced TNFα (P <0.001) and IL-1β (P <0.03) at 4 hours,
and HO-1 (P <0.028) at 24 hours compared with saline. Honey
prolonged the time of PT and APPT in a dose-dependent manner.
Conclusions  Honey behaves as immunomodulator by acting in
two ways, by inducing HO-1, TNFα, and IL-1β and at the same
time inhibiting cytokines, NO and HMGB1 that is induced by LPS.
However, the exact mechanism remain unclear, but our suggestion
is that since honey induces HO-1, TNFα and IL-1β this may cause
changes or inhibition in the signaling of cytokines and NF-κB.
Honey could therefore be used as a pharmacological tool in sepsis
in the future.
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Introduction  Laboratory diagnostics of sepsis need to be
improved. There is no evidence in the literature whether microbial
metabolites could be used as sepsis markers. As a result of large-
scale screening of microbial compounds we showed that levels of
some phenylcarboxylic acids (PCAs) were increased in blood of
septic patients. The content of p-hydroxyphenyllactic acid (HPLA),
phenyllactic acid (PLA) and p-hydroxyphenylacetic acid (HPAA)
was significantly higher in blood of patients with severe sepsis
compared with control groups. The aim of the present study is to
evaluate the sensitivity and specificity of PLA, HPLA and HPAA as
markers for severe sepsis diagnostics.
Methods  In total, 264 blood samples from 200 adults were
included to research. All persons were divided into groups with
infectious complications after cardiosurgery (35 severe sepsis, 35
local infection complication) and others (33 non-infection compli-
cation after surgery, 30 smooth recovery after surgery, 42 before
surgery and 25 healthy volunteers). Clinical characteristics and
procalcitonin (PCT), a well established biomarker of sepsis, were
assessed in all patients. Severe sepsis was diagnosed according
to consensus criteria, also a level of PCT ≥2 ng/ml was an
additional criterion. Blood concentrations of PCAs were deter-
mined by gas chromatography–mass spectrometry.
Results The levels of PCA in two control groups (healthy people
and patients before surgery) were HPAA 0.4 to 0.8 x 10–6 M,
HPLA 1.2 to 1.5 x 10–6 M, PLA 0.3 to 0.4 x 10–6 M and were not
significantly different. Otherwise the levels of HPAA, HPLA and
PLA as 11.6 (3.3 to 33.6) x 10–6 M, 7.5 (3.0 to 14.4) x 10–6 M and
1.8 (1.1 to 4.9) x 10–6 M in all severe sepsis patients were
significantly increased versus control groups and versus all other
groups (P <0.0001). In addition the levels of PCAs from surviving
and nonsurviving severe sepsis patients were compared with each
other. Nonsurviving sepsis patients had a significantly higher content
of PLA (3.6 (1.5 to 6.4) x 10–6 M vs. 1.2 (0.8 to 1.6) x 10–6 M for
survivors); the same trend was observed for HPLA (12.5 (5.6 to
34.7) x 10–6 M vs. 2.8 (2.2 to 5.0) x 10–6 M correspondingly), but
not for HPAA.
Conclusions  The following levels of PCAs are appropriate for
diagnostic of sepsis: HPAA 8 x 10–6 M (sensitivity 64.3%, speci-
ficity 88.9%), HPLA 3 x 10–6 M (sensitivity 75%, specificity
66.4%), PLA 1 x 10–6 M (sensitivity 75%, specificity 71.6%).
Obtained data indicate that quantitative measurement of PLA,
HPLA and HPAA in blood could be used for sepsis diagnostics in
clinical practice and also as a predictor of outcome in high-risk
surgery.
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Introduction Sepsis is an uncontrolled infection that can develop
very quickly throughout the body. Sepsis can strike anyone at any
age and people with pre-existing medical conditions may be at
greater risk. Patients with sepsis often present to the emergency
department from home. Community education programs focus on
raising public awareness of sepsis, its signs and symptoms, and
can positively impact outcomes.
Objective  A multidisciplinary public health campaign was
developed to educate a local urban community about recognizing
the signs and symptoms of sepsis, preventing infection, and
seeking treatment early. Targeting education efforts at the
community level engages consumers to become involved in the
care of their health.
Methods  A multimedia approach including print, television
broadcast, hospital website on the Internet, news article and
advertisement in the newspaper were widely distributed to
maximize the ability to reach citizens throughout the area. A live
seminar presented by two physicians and a clinical nurse specialist
was strategically used to enhance learning, and participants
completed an evaluation upon completion of the seminar.
Results Ninety-six percent of the participants who attended the
live seminar rated the program as excellent. The participants
shared that the topic was very educational, informative, and felt
that their questions were answered. Because of the education
media campaign that targeted 320,000 households and the
hospital-wide implementation of the sepsis bundles, the mortality
for severe sepsis decreased from 40% at baseline to 32.8%,
which was a 18% relative risk reduction (Figure 1).
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Severe sepsis mortality.S20
Conclusions This community-based education program on sepsis
demonstrated that education programs offered to the community
will improve overall outcomes and promote quality care of sepsis
patients. In the pursuit of evaluating the effectiveness of the
program, there will be ongoing monitoring of its impact. Future
education programs will continue to sustain improvements.
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Introduction  Sepsis is an acute systemic inflammation following
infection, with a high mortality rate and limited therapeutic options.
IL-33 is a recently identified member of the IL-1 family that binds to
ST2 receptor, which is preferentially expressed on Th2 and mast
cells. Accordingly, the IL-33/ST2 pathway is closely associated with
the activation and production of type-II cytokines (IL-4, IL-5 and IL-
13). However, ST2 has been implicated in inhibiting macrophage-
dependent inflammation in response to LPS by negatively regulating
Toll-like receptor-4 (TLR4) activation. Although TLRs have been
implicated as an important element of host defense against
infections, evidence indicates that these receptors may also play a
detrimental role in the pathophysiology of sepsis.
Objective  To investigate the role of the IL-33/ST2 pathway in
experimental sepsis.
Methods and results We show that IL-33 treatment (1 μg/mouse,
intravenously) markedly reduced mortality in WT mice (50%,
P <0.01) undergoing experimental sepsis induced by the cecal
ligation and puncture (CLP) model. We did not detect any
differences between ST2 KO and WT mice in peritoneal bacterial
load and mortality rate after CLP, suggesting that the endogenous
IL-33 does not participate in the pathophysiology sepsis. However,
while the exogenous injection of IL-33 markedly reduced the CLP-
induced mortality in WT mice, IL-33 failed to do so in ST2–/– mice,
indicating the critical role of ST2 on the protective effect of IL-33.
Notably, we found that IL-33-treated mice developed significantly
increased neutrophil infiltration in the peritoneal cavity (fourfold) and
more efficient bacterial clearance than untreated mice (n = 10) after
CLP. Moreover, IL-33 treatment leads to marked reduction (30 to
70%) of systemic proinflammatory cytokines (TNFα, IL-6 and
CXCL2) but not a shift toward a Th2 immune response (IL-4 and
IL-13). The chemokine receptor CXCR2 plays a central role in the
recruitment of neutrophils into the site of infection. Flow cytometry
analysis showed that direct activation of TLR4 in neutrophils
downregulates the expression of CXCR2 and, consequently,
impaired CXCL2-driven and CLP-driven neutrophil migration, in
vitro and in vivo respectively. Notably, IL-33 prevented the
downregulation of CXCR2 on circulating neutrophils during CLP in
vivo or LPS-treated neutrophils in vitro. Finally, we demonstrated
that IL-33 reversed the TLR4-induced reduction of CXCR2 via the
inhibition of LPS-induced G-protein-coupled receptor kinase-2
(GRK2) expression, a potent negative regulator of CXCR2.
Conclusions Altogether we provide here a novel mechanism of
action of IL-33 and establish a potential therapeutic role of this
new cytokine in sepsis.
Acknowledgements Financial support from Wellcome Trust, MRC
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Introduction  The ability to rapidly identify and determine the
antimicrobial susceptibility of bacterial pathogens is an undisputed
requirement for strategies aimed at improving the management of
sepsis. Staphylococci are amongst the most common organisms
isolated from blood cultures but it is difficult to rapidly distinguish
between those representing contamination of the blood culture
with harmless skin commensals (Staphylococcus epidermidis) and
those that contain pathogenic species (Staphylococcus aureus).
Objective A number of phenotypic and genotypic tests with a vast
range of complexity, speed and cost have been proposed to help
distinguish these organisms. We evaluated the sensitivity, specificity
and speed of a range of these tests compared with the standard
laboratory identification protocol which takes up to 48 hours.
Methods Positive blood culture sets (BACT/Alert 3D) (n = 113) in
which Gram-positive cocci in clusters were seen on the initial film
were included. Further identification as S. epidermidis versus
S. aureus was attempted using the following techniques directly
from the positive bottles: (1) morphology and organization of the
cocci on Gram stain (10 minutes), (2) rapid tube coagulase
(2 hours), (3) direct DNAse test using toluedine blue agar (4
hours), (4) species-specific multiplex PCR (4 hours), (5) direct
inoculation of selective commercial chromogenic media (18 hours),
and (6) direct inoculation of mannitol-supplemented
Mueller–Hinton agar (MMHA) combined with disc diffusion
susceptibility testing (18 hours). Identifications were compared
with the standard laboratory identification at 36 hours.
Results Definitive laboratory identification revealed S. epidermidis
87% (n = 98), S. aureus 11% (methicillin-sensitive S. aureus
(MSSA)  n = 9, methicillin-resistant S. aureus (MRSA)  n = 3),
Micrococcus spp. 2% (n = 2); one culture contained a mixture of
S. aureus and  S. epidermidis. The sensitivity and specificity of
each of the direct techniques was calculated as follows: (1)
microscopy 53% and 98%, (2) rapid coagulase 92% and 100%,
(3) direct DNAse 69% and 98%, (4) multiplex PCR 88% (no
amplification in 12 samples) and 99%, (5) chromogenic S. aureus
media 90% and 100%, and (6) MMHA 100% and 78%.
Conclusions  All the methods had specificity >95%, except for
MMHA, although this has the added advantage of providing
susceptibility results. Chromogenic agar had the highest sensitivity
and specificity, although it provided a result only 12 hours quicker
than the standard protocol. Rapid tube coagulase was highly
specific and one of the most rapid tests. This may be the most
useful, inexpensive technique providing preliminary results to guide
empirical therapy, especially in resource-poor settings.
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Introduction Several retrospective studies suggest that prior use
of statins can reduce hospital mortality in patients diagnosed with
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either bacteraemia or sepsis. In an accompanying abstract we
demonstrated that pre-treatment with simvastatin prevents LPS-
induced hyporesponsiveness of the porcine isolated coronary
artery (PCA); an observation consistent with the clinical data.
Although this effect of simvastatin is qualitatively similar to that of a
known inhibitor of inducible nitric oxide synthase (1400W), it
unlikely that direct inhibition of the enzyme is implicated. We have
investigated whether the beneficial effect of simvastatin on LPS-
induced changes in the PCA involves alteration in the induction of
nitric oxide synthase (iNOS).
Methods Segments of the PCA were dissected from hearts and
incubated (2 x 5 mm) in DMEM at 37°C in the presence of an
antibiotic mixture (60 μg/ml benzylpenicillin, and 20 μg/ml strepto-
mycin sulphate), with or without 1 μg/ml LPS, 3 μM simvastatin or
a combination of the two (simvastatin added 60 minutes before
LPS). The medium also contained 1 mM L-arginine. After 24 hours,
segments were removed and weighed (mg wet weight). The
nitrite/nitrate content (nmol) of the bathing medium was deter-
mined by spectrophotometry using the Griess reaction. In a
separate experiment, segments were prepared for immunohisto-
chemical determination of the presence of iNOS and CD31.
Differences between mean values were assessed by ANOVA
(post-hoc Dunnett test).
Results  Under control conditions the coronary artery segments
produced 25.9 ± 3.7 nmol/mg wet weight nitrite/nitrate (n = 8)
over 24 hours. Exposure to 1 μg/ml LPS caused a sevenfold
increase in nitrite/nitrate production (199.0 ± 40.6 nmol/mg wet
weight, n = 8). Although 3 μM simvastatin did not affect basal
nitrite/nitrate production, it inhibited the response to LPS
(35.6 ± 7.4 nmol/mg wet weight nitrite/nitrate) by 94.7 ± 5.7%
(n = 8). Immunohistochemical assessment of four arteries revealed
the presence of CD31 on endothelial cells under control
conditions. Exposure to 1 μg/ml LPS was associated with an
increase in endothelial CD31 and the appearance of iNOS in the
adventitia. Co-incubation of segments with 3 μM simvastatin and
LPS produced a profile similar to that of control segments (CD31-
positive, iNOS-negative, n = 4).
Conclusions Simvastatin suppressed the induction of nitric oxide
caused by LPS and the associated increase in nitrite/nitrate
production. This finding helps to explain our observation that
simvastatin prevented LPS-induced hyporesponsiveness of the
coronary artery, and is also consistent with clinical studies
suggesting that prior use of statins may afford protection against
bacterial sepsis.
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Introduction Several retrospective studies suggest that prior use
of statins can reduce hospital mortality in patients diagnosed with
either bacteraemia or sepsis. Simvastatin has been shown to
modify the proinflammatory effect of lipopolysaccharide (LPS) on
neutrophils and endothelial cells. However, it is not clear whether
these effects are also manifest on vascular smooth muscle, which
becomes hyporesponsive to vasoconstrictor agents due to the
induction of nitric oxide synthase. We have investigated the effect
of pre-treatment with simvastatin on LPS-induced changes in
contractions of porcine isolated coronary artery (PCA).
Methods  Segments (5 mm) of the PCA were dissected from
hearts and incubated in Krebs–Henseleit (K–H) solution at 37°C in
the presence of an antibiotic mixture (60 μg/ml benzylpenicillin and
20  μg/ml streptomycin sulphate), with or without 1 μg/ml LPS,
3 μM simvastatin or a combination of the two (simvastatin added
60 minutes before LPS). After 16 to 18 hours, segments were
prepared for isometric tension recording in K–H solution. The
segments were then exposed to cumulatively increasing concen-
trations of KCl and then U46619. In some experiments, some
segments were exposed to 10 μM 1400W, a selective inhibitor of
inducible nitric oxide synthase prior to the addition of the agonists.
Responses are shown as gram weight or calculated as the
concentration causing 50% of the maximum effect (–log EC50).
Differences between mean values were assessed by ANOVA
(post-hoc Dunnett test).
Results KCl and U46619 caused concentration-dependent
contraction of the PCA. Table 1 shows that treatment with 1 μg/ml
LPS overnight (and subsequent removal) significantly reduced the
maximum response to KCl and U46619 in the PCA by
32.0 ± 4.5% (n = 12) and 28.9 ± 12.3% (n = 12), without
changing the potency of either agent. These effects of LPS on
vasoconstrictor responses were not observed when 10 μM
1400W was added to the organ bath, after removal of the
endotoxin (Table 1). LPS also failed to impair constrictor responses
if 3 μM simvastatin was present during the incubation period and
was subsequently removed (Table 1).
Available online http://ccforum.com/supplements/13/S4
Table 1 (abstract P46)
Effect of LPS, 1400W and simvastatin on maximum response and potency of vasoconstrictor agent on the PCA
KCl U46619
Incubation conditions Maximum (g wt) –log EC50 Maximum (g wt) –log EC50
Control (n = 12) 10.23 ± 0.71 1.56 ± 0.04 10.39 ± 0.71 7.52 ± 0.08
LPS 6.83 ± 0.48* 1.60 ± 0.04 6.77 ± 0.80** 7.64 ± 0.06
LPS then 1400W 9.35 ± 1.21 1.64 ± 0.06 9.41 ± 0.46 7.54 ± 0.04
Control (n = 18) 12.13 ± 0.58 1.55 ± 0.01 13.46 ± 0.51 7.83 ± 0.01
LPS 8.41 ± 0.58** 1.51 ± 0.02 9.90 ± 0.47** 7.75 ± 0.06
Simvastatin and LPS 11.82 ± 0.34 1.53 ± 0.03 13.92 ± 0.38 7.73 ± 0.04
Data presented as mean ± SEM (n = 12 to 18). *P <0.05, **P <0.01, denotes a statistically significant difference from control.S22
Conclusions Prolonged exposure to LPS caused hyporesponsive-
ness of the PCA by a mechanism that appears to involve the
induction of nitric oxide synthase. Since pre-treatment of the PCA
with simvastatin reduced LPS-induced changes in vasoconstrictor
responses, it unlikely that the effect of the statin involves direct
inhibition of NOS (compare 1400W). These findings are consis-
tent with clinical studies suggesting that prior use of statins may
afford protection against bacterial sepsis.
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Introduction  Colorectal surgery carries significant risks of
postoperative morbidity and mortality. One of the major hazards is
an increased risk of sepsis; an important component of which is
systemic inflammatory response syndrome (SIRS). Several recent
studies suggest that the noncholesterol-related, pleiotropic effects
of statins may limit the development of sepsis and associated
inflammation. This study investigates the impact of prior statin
therapy on the incidence and outcome of postoperative sepsis and
SIRS in colorectal surgery patients.
Methods  A retrospective cohort analysis of 577 patients who
underwent curative surgery for colorectal cancer was conducted to
evaluate postoperative morbidity and mortality (within 30 days of
surgery). The primary endpoints were: 30-day in-hospital mortality,
admission to intensive care (ICU), and a positive diagnosis of SIRS
or sepsis.
Results Prior to admission, 21.7% of patients were taking either
simvastatin, atorvastatin, fluvastatin, pravastatin or rosuvastatin.
Patients on statins were significantly older than those not on
statins (statin – 74.7 years (SD = 6.5) vs. nonstatin – 69.2 years
(SD = 13.4), P = 0.022), more likely to have pre-existing co-
morbidities and in receipt of antidiabetic agents and other
cardiovascular drugs. Table 1 shows there was no difference in
mortality rate between the two groups. Furthermore, the incidence
of nosocomial infection and sepsis did not differ between the statin
and nonstatin groups. Despite being more likely to be admitted to
the ICU, the statin group was significantly less likely to develop
either SIRS (in or out of the ICU) or postoperative wound infection
or be admitted to the ICU for infective/inflammatory sequelae.
Conclusions  Statin patients were older than nonstatin patients,
and had a greater burden of co-morbidities, yet the mortality rate
did not differ between the two groups. The possibility that prior use
of statins may influence inflammatory or infective events associated
with this surgical procedure is supported by the significantly lower
incidence of wound infection, SIRS and sepsis in statin-treated
patients, illustrating the potential for statins to confer protection
against these insults in the most critically ill patients.
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Introduction  Multiple organ dysfunction syndrome (MODS)
frequently complicates sepsis contributing to poor outcome. Yet
the evolution of MODS in the early septic mortality (ESM) is
unclear. To delineate the ESM–MODS relationship, we compared
the development and magnitude of organ injury between dying and
surviving mice in the acute phase (days 1 to 5) of polymicrobial
sepsis.
Methods Female OF-1 mice were subjected to cecal ligation and
puncture (CLP). In the first mouse subset, 20 μl blood was
collected daily for 5 days or until death (mice followed for 28 days).
To define the pre-lethal changes in circulating parameters, mice
were retrospectively divided into two groups based on outcome in
the acute sepsis: DEAD (all died within 5 days, n = 39) and
survivors (SUR; alive at day 28, n = 40). In the second subset,
mice were sacrificed within 24 hours of projected death (based on
the body T <28°C, 100% specificity, n = 7) and matched with
SUR (body T >35°C, 100% sensitivity) from the same post-CLP
day and controls.
Results  In the first subset, significant difference was observed
between SUR and DIED in the circulating urea, ALT, LDH and
glucose during the 1-day to 5-day time course but the magnitude
of these changes varied among post-CLP days. Therefore, we
used the day of death as a reference point clustering all pre-lethal
parameter values as the 72, 48 and 24 hours prior-to-death (on
any 1 to 5 post-CLP day) time points for comparison with the SUR
values. A significant separation between SUR and DIED occurred
generally at 24 hours prior to death: pre-lethal urea increased to 78
(vs. 40 mg/dl in SUR), ALT to 173 (vs. 106 U/l) and LDH to 798
(vs. 445 U/l), while pre-lethal glucose declined to 41 (vs.
74 mg/dl). In the second subset (only 24 hours prior-to-death time
point), acute deaths were not preceded by a significant rise in
creatinine (DIED 6.8 vs. 4.3 μM/l in SUR) and troponin I (239 vs.
119 pg/ml). Similarly, respiratory function of mitochondria in the
liver and kidney was not impaired in either DIED and SUR
compared with controls. Injury scores in the liver, kidney, heart and
lung showed no apparent morphological disparity between
moribund, surviving or control mice. Incidence of cell apoptosis
(TUNEL) in organs was not increased in either of the groups.
Conclusions  The increase of selected organ function/metabolic
markers was manifested at least 24 hours prior to death. Despite
statistical significance, the relatively small magnitude of these
changes questions organ failure as a direct cause of death in the
early phase of CLP sepsis.
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Table 1 (abstract P47)
Outcomes for statin and nonstatin patients following colorectal
surgery
Parameter Statin Nonstatin Sig.
Overall mortality 9/125 (7.2%) 27/452 (6.4%) 0.77
Nosocomial infections 42/125 (33.6%) 132/452 (29.2%) 0.40
Sepsis 10/75 (13.3%) 42/203 (20.7%) 0.22
SIRS 16/125 (12.8%) 148/452 (32.7%) <0.001
Wound infection 11/125 (8.8%) 66/452 (14.6%) 0.04
Admitted to the ICU 34/125 (27.2%) 63/452 (13.9%) <0.001
Sig,. significance.S23
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Introduction Sepsis is defined by the systemic response to an
infection, governed by dynamic interactions between the tissues,
immune cells and inflammatory mediators. We used the
Immunetrics platform to build a large-scale mathematical model
that encompasses these biological components. The model
incorporates a virtual clinician, an automated system to examine
simulated patients’ status at clinically relevant intervals and
administer standard of care interventions as necessary, thereby
altering the dynamics of the disease state. The model reproduces
many characteristics of systemic response to an infection,
including the time course of cytokines, coagulation factors, clinical
markers, early and late organ failure, and early versus late deaths.
Methods The ordinary differential equation-based model was used
to simulate the progression of sepsis over a 30-day hospital stay.
This model was fit to published human endotoxemia data as well as
data from severely septic community-acquired pneumonia (CAP)
patients from the GenIMS study. The model was fit to 15
biomarkers and clinical markers, including mean arterial pressure,
PaO2, creatinine, TNFα, IL-6, and PAI-1.
Results Figure 1 illustrates simulated output as compared with the
median time course data for surviving CAP patients without co-
morbidities and for CAP patients without co-morbidities who died
between 4 and 8 days after admission. After incorporating
changes in physiological and immune function due to patient
demographics and co-morbidities (for example, COPD, cardio-
vascular disease), a handful of parameters were changed to fit the
model to median time course data from 14 subgroups. These
parameters included pathogen virulence, effectiveness of anti-
biotics, baseline status of patients at study inclusion, and
occurrence of secondary infection. By overlaying variations in the
above parameters about the median model, the model can
encompass the entire spectrum of patients observed in the
GenIMS study. The virtual clinician administers individualized
treatment for each simulated patient. The model simulations
provide clear evidence of changes in disease progression as a
function of differences in treatment.
Conclusions The ability of our model to reproduce a large variety
of patients with a relatively small number of parameter changes
illustrates the robustness of the underlying biological processes
being modeled. The model may help identify real signals in
immensely variable and noisy multidimensional sepsis patient data,
and distinguish real patient responses from clinical study-site-
related variability. This model is currently undergoing further
validation. Future capabilities include assessment of risk and
benefit of new drugs for sepsis or new treatment strategies (for
example, early goal-directed therapy) in different patient cohorts.
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Introduction The assessment of heart rate variability (HRV) has
provided valuable insight in sepsis. Impaired HRV has been shown
Available online http://ccforum.com/supplements/13/S4
Figure 1 (abstract P49)
Comparison of time course data from model simulation (solid line) and median of patients (filled circles) from (a) surviving CAP patients without co-
morbidities and (b) CAP patients without co-morbidities dying between 4 and 8 days after admission.S24
to be diagnostic of sepsis, heralding its onset, and prognostic of its
impact, correlating with the development of sepsis-induced organ
failure and death.
Objective To analyze the ability of HRV to act as a prognostic aid
in the early resuscitation of septic shock, and to study the effect
that early fluid resuscitation will have on the direction and
magnitude of subsequent measurements of HRV in patients with
septic shock.
Methods  Subjects were prospectively identified within the
emergency department of an urban-based tertiary-care medical
center during their initial evaluation and treatment for septic shock,
defined as a systemic infection with a systolic blood pressure
<90 mmHg after intravenous fluid or a serum lactate >4.0 mmol/l.
Continuous cardiac telemetry was obtained for the assessment of
HRV using a standardized set of multiple parameters including
variables of frequency and time domain analyses. Fluid
administration was recorded during the initial resuscitation. A
composite endpoint of increasing organ failure and in-hospital
mortality was measured.
Results Prospective analysis of 15 patients with septic shock was
made. The in-hospital mortality rate was 67% (10/15). Non-
survivors had a significantly impaired HRV compared with survivors
when measured through multiple parameters (P < 0.01), as seen in
Figure 1. There was no difference between fluid administration
between survivors and nonsurvivors (4,475 vs. 5,220 ml, P = NS).
There was no relationship seen between intravenous fluid
administration and the change in 2-hour HRV seen in the early
resuscitation of septic shock.
Conclusions  In the early resuscitation of septic shock, HRV
assessment can differentiate survivors from nonsurvivors,
independent of organ severity measurement. While the use of fluid
administration in the early resuscitation of shock did not correlate
with changes in HRV measured at 2 hours, this relationship may
exist when measured at longer time points allowing for the
physiologic response to manifest in the HRV trend. The
assessment of HRV in patients with infection can identify those at
high risk for clinical deterioration and can potentially serve as an
endpoint of resuscitation in patients with septic shock.
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Introduction  Critically ill patients often have abnormally low
plasma thyroxine (T4) concentrations even in the absence of
thyroidal illnesses, with the lowest T4 values being observed in
patients (particularly older individuals) with sepsis. Staphylococcal
infection of the lung is the most common presentation of sepsis in
the medical ICU setting, and is associated with a much higher
mortality in older individuals than in younger. In studies where the
lungs of rats are challenged with staphylococcal components
lipoteichoic acid and peptidoglycan, we have noted negative corre-
lations between plasma MIF and T4.
Objective To examine the dynamics of MIF and T4 in a clinically
relevant, large animal model of sepsis.
Methods Adult female sheep (30 to 40 kg) with age approximately
equivalent to humans of 55 years were surgically prepared for
chronic study. After 5 days recovery, approximately 2.5 x 1011 CFU
methicillin-resistant Staphylococcus aureus (ATCC 4300, a clinical
isolate) were instilled into the lung via a bronchoscope. The
animals were ventilated, and hemodynamics were monitored
continuously for 24 hours post instillation. Blood and lymph
samples were collected at baseline and at 3, 6, 12, 18, and
24 hours. MIF was measured by semiquantitative western blot and
free-T4 by ELISA.
Results  The plasma concentration of MIF increased from
24.9 ± 4.5 ng/ml at baseline to 30.1 ± 2.5 ng/ml in the first 6 hours
post instillation of the bacteria. During this time period, free-T4
concentration decreased from 1.6 ± 0.5 ng/dl to 0.4 ± 0.3 ng/dl.
The concentration of MIF in the pulmonary lymph was approxi-
mately 10% of the plasma level, and showed no time-dependent
decrease, although the lymph flow increased approximately
fourfold over the course of the study.
Conclusions  We have found that intratracheal instillation of
staphylococcal cell wall components in rats results in an imbalance
of plasma MIF and free-T4, and that pulmonary-derived MIF in
sepsis induces cardiocirculatory depression. Here we show that, in
a clinically relevant, large animal model of sepsis induced by
pulmonary infection with methicillin-resistant S. aureus, increased
plasma concentration of MIF and decreased free-T4 occurred in a
similar manner to our rat studies, and that the total amount of MIF
in the lymph also increased. Since strong negative correlations
exist between prognosis and levels of T4 or MIF in patients with
sepsis, our findings underscore interest in possible interactions
between the MIF and T4 molecules that may be critical for the
outcome of the disease.
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Figure 1 (abstract P50)
Heart rate variability parameters measured during the initial
resuscitation of patients with septic shock. Nonsurvivors showed
significantly impaired variability as measured by LF and the HF/LF ratio.
Data presented as logarithmic transformation to control for scale and
allow visual comparison. Differences between survivors and
nonsurvivors were calculated using raw averages without logarithmic
conversion. Time domain factors: SDNN = standard deviation of the
normal R–R interval; RMSSD = root mean square of the difference of
successive R–R intervals. Frequency domain factors of HRV spectrum:
LF = low frequency (0.04 to 0.15 Hz); HF = high frequency (0.18 to
0.4 Hz).S25
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Introduction Macrophage migration inhibitory factor (MIF) is a pro-
inflammatory cytokine that plays a critical role in the pathogenesis
of sepsis. Plasma MIF concentrations are significantly higher in
nonsurvivors than survivors of severe sepsis, and administration of
antibodies that neutralize MIF activity improves survival in an
experimental model of sepsis. Three-dimensional X-ray crystallo-
graphy shows MIF has a homotrimeric conformation and we have
determined that the hydrophobic cavity formed between two
adjacent subunits of the homotrimer is required for the pro-
inflammatory activity of the molecule. We have designed several
small molecules that fit into the site critical for the proinflammatory
action of MIF, and confirmed the interaction by the crystal structure
of the MIF complex. Binding of MIF in this way inhibits its
proinflammatory activity, improves the clinical outcome in sepsis,
and recapitulates immunotherapy and gene deletion. However, no
natural soluble ligand of MIF has been reported previously.
Hypothesis  MIFnl1 binds to the hydrophobic cavity of MIF.
Increased concentrations of MIF in sepsis deplete plasma MIFnl1
and lead to a critical MIF:MIFnl1 imbalance.
Results We have discovered a natural ligand, designated MIFnl1,
that binds the proinflammatory site of MIF with high affinity, and
effectively modulates its activity. We examined several classes of
endogenous small molecules and their metabolites and observed
that MIFnl1 binds to, and inhibits, the hydrophobic cavity of MIF in
a dose-dependent manner with an IC50 of 15.8 μM. Importantly,
MIFnl1 was a more potent inhibitor of MIF than ISO-1 (IC50 =
25 μM), the gold standard synthetic inhibitor of MIF. In addition, in
plasma from patients with sepsis, we found an inverse correlation
between the increased level of MIF and the decreased
concentration of MIFnl1. Therefore, we hypothesized that
supplementation of this ligand during sepsis should compensate
for its dramatic reduction and improve survival in our peritonitis
model of sepsis in C57/Bl6 mice. Administration of MIFnl1
improved the 7-day survival rate to 60% compared with 20%
observed for the vehicle-treated mice.
Conclusions Our data identify for the first time the presence of a
natural, ligand antagonist of MIF in plasma. This suggests that,
during severe sepsis, increased production and release of MIF
leads to an imbalance of the MIF:MIFnl1 regulatory mechanism
resulting in the development of an overwhelming systemic
inflammatory response leading to cardiovascular collapse and
death. A better understanding of the kinetics of MIF/ligand
regulation in patients with sepsis may lead to improved outcome in
this devastating disease.
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Introduction Sepsis, the systemic inflammation following infectious
insult, is a major cause of morbidity and mortality particularly in
older individuals. While most animal models of sepsis have studied
polymicrobial or Gram-negative sepsis from an abdominal origin in
young animals, the most common presentation in the medical ICU
is in older individuals (median age 64 years), with Gram-positive
bacteria (predominantly Staphylococcus aureus) infection in the
lung. Our recent studies reveal a critical role for macrophage
migration inhibitory factor (MIF) in the pathogenesis of sepsis, and
thyroxine (T4), two molecules with major implications in sepsis.
Therefore, we reasoned that the age-related severity of sepsis may
be due to an exaggerated imbalance between MIF and its inhibitor.
Objective To examine age-dependent differences in inflammatory
responses following pulmonary staphylococcal challenge.
Methods  Lipoteichoic acid (LTA) and peptidoglycan (PGN) are
major inflammatory components of the staphylococcal cell wall
known to induce shock. Male Fischer 344 rats either Young
(6 months) or Old (>18 months), approximately equivalent to
humans of 18 and 60 years respectively, were anesthetized and
LTA and PGN (1.5/5 mg/kg in 200 μl) were administered intra-
tracheally. Six hours later, blood was collected from the heart, and
post mortem, the lungs were lavaged for analysis of the epithelial
lining fluid. Young, untreated cage control animals (Control) were
also assessed.
Results The plasma MIF concentration significantly increased with
LTA/PGN challenge (Control, 24.9 ± 0.6 ng/ml; Young, 38.8 ±
5.9 ng/ml; Old, 64.2 ± 12.1 ng/ml) and the mean concentration in
the old animals was significantly higher than in the young;
P = 0.004. Conversely, plasma free-T4 significantly decreased with
LTA/PGN challenge (Control, 2.3 ± 0.9 ng/dl; Young, 1.7 ± 0.7 ng/dl;
Old, 1.0 ± 0.4 ng/dl) and the mean concentration in the old
animals was significantly lower than in the young; P <0.05.
Significant age-specific differences were also noted in the
response with respect to neutrophils and IL-6 within the lavage
fluid.
Conclusions  Typically, critically ill patients have abnormally low
plasma T4 concentrations even in the absence of thyroidal
illnesses (the so-called euthyroid sick phenomenon) with the
lowest values being observed in septic and/or elderly individuals,
suggesting a strong negative correlation between prognosis and
T4 concentration. The data suggest that an increased early
inflammatory response in older compared with young animals
results in an exaggerated imbalance between MIF and T4, possibly
leading to development of an uncontrolled systemic response.
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Introduction Mortality from sepsis is greater in the elderly than in
the young although incidence only increases slightly. Pulmonary
infections caused by Staphylococcus aureus, which progress into
sepsis, are a major cause of death in elderly patients. Adiponectin,
multifaceted adipokine with anti-inflammatory properties, is
secreted primarily from adipose tissue. It is increasingly
acknowledged that the tissue microenvironment changes with old
age. With increasing age, ectopic fat accumulates, increasing the
possibility of elevated levels of adipose-derived mediators in the
older individual.
Objective  To investigate age-dependent changes in the intra-
pulmonary response to staphylococcal challenge. We hypothesized
Available online http://ccforum.com/supplements/13/S4S26
that older animals have higher levels of adiponectin due to adipose
tissue accumulation and that these levels will neutralize the
proinflammatory consequences of staphylococcal stimulation of
the lung.
Methods Young (6 months) and old (>18 months) male Sprague–
Dawley rats were challenged intratracheally with S. aureus cell wall
components lipoteichoic acid (LTA, 0.15 mg) and peptidoglycan
(PGN, 0.5 mg) or saline alone. After 24 hours, plasma was
collected and lungs lavaged post mortem. Concentrations of total
protein, chemokines and MIF were assessed. In vitro studies
examined the accumulation of adiponectin in the culture medium of
the adipocyte cell line 3T3-L1 following direct challenge with
LTA/PGN (3 μg/ml; 100 μg/ml) for 6 hours.
Results  The older age group, compared with the young group
receiving the same stimulus, showed significantly elevated alveolar
levels of MIF and CXCL1 (KC), both involved in neutrophil
recruitment. Neutrophils (controls: 0.029 ± 0.033, young: 13.9 ±
7.8, old: 29.3 ± 10.5, x 106) and the total number of cells
(controls: 0.72 ± 0.26, young: 16.4 ± 9.7, old: 32.9 ± 11.2, x 106)
within the alveolar space were significantly and age-dependently
increased, following pulmonary insult. Plasma adiponectin did not
change significantly. However, instillation of LTA/PGN significantly
elevated the levels of adiponectin found within the alveolar space
(controls: 3.9 ± 2.4, young: 22.5 ± 8.8, old: 29 ± 10.8 ng/ml,
P <0.01). Interestingly, following LTA/PGN challenge of
adipocytes, there was a significant decrease in adiponectin
concentration in the culture medium (control: 20.3 ± 0.78,
LTA/PGN: 18.23 ± 1.14 pg/ml, P = 0.016).
Conclusions  The proinflammatory but not anti-inflammatory
components of the immune response (assessed by neutrophil
recruitment and adiponectin concentrations, respectively) differed
significantly between the age groups. Since adiponectin
decreased on direct stimulation of adipocytes, the increased
adiponectin within the lungs may reflect increased lung perme-
ability, and/or production by other cells within the lung. These
findings are important in understanding the response to pulmonary
infections in the older patient and may lead to the identification of
novel targets for age-dependent therapeutic strategies.
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Introduction High mobility group box 1 (HMGB1) is a pleiotropic
cytokine, implicated in the pathophysiology of sepsis. This alarmin,
usually located in the nucleus, is released after tissue injury and
activates various innate immunity receptors, leading to sustained
inflammatory response. Inhibition of HMGB1 by anti-HMGB1
antibodies has been reported to decrease mortality in experimental
models of sepsis. In the present work, we analyse whether
HMGB1 secretion during septic shock leads to the production of
naturally acquired anti-HMGB1 antibodies during septic shock.
Methods  All patients with septic shock criteria and no
immunosuppression were included during a 6-month period of
time. After informed consent, blood samples (200 μl) were drawn
on the day of shock and at D3, D7, and D14. Plasma HMGB1
levels were measured, using a commercial ELISA kit (Sino-Test
Corporation, Sagamihara, Japan). Auto anti-HMGB1 antibodies
were detected in serum by a homemade ELISA test.
Results  Forty-two septic shock patients were included. Median
age was 70 (59 to 78) years, SAPS 2 was 68 (51 to 83), and the
mortality rate was 29%. HMGB1 was undetectable in the plasma
of a control population. In contrast, high levels of HMGB1 were
found in all septic patients (median = 5.71 ng/ml at D7). Thirteen
patients (38%) presented a significant production of auto anti-
HMGB1 IgG antibodies during the course of sepsis. The age, sex
ratio, median HMGB1 level and mortality rate were similar in
patients producing (PPAb) and not producing antibodies (PNPAb).
However, as compared with the PNPAb patients, the PPAb group
had significant higher APACHE II (P = 0.027) and SOFA scores
(P = 0.02) at the onset of shock and had a more important but
nonsignificant decrease of the cardiovascular SOFA score
between day 1 and day 7 (P = 0.063).
Conclusions  Naturally acquired anti-HMGB1 antibodies are
produced during septic shock. The presence of antibodies is
associated with higher severity scores and might be associated
with an improvement of the haemodynamic dysfunction. The
neutralizing capacity of these autoantibodies and their physio-
logical role remain to be investigated.
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Introduction Septic shock (SS) remains a serious disease with
high mortality and increased risk of hospital-acquired infection
(HAI). Access to biomarkers assessing prognosis of these
outcomes is of utmost importance in order to select patients for
future therapeutic strategies. Alarmins are normal cell constituents
that can be released into the extracellular milieu during states of
cellular stress and subsequently activate the innate immune
system. Several alarmins of the S100 family are released by
phagocytes in response to cell stress, recognized by RAGE and/or
TLR4 on monocytes and therefore highlighted as relevant mediators
in sepsis pathophysiology. Among them, S100A8 and S100A9
exist mainly as a heterodimer called calprotectin. However, several
studies suggest independent functioning of S100A9, making it an
interesting candidate biomarker in septic syndromes.
Objective To assess capacity of S100A9 mRNA in whole blood
from SS patients to predict survival and the occurrence of HAI.
Methods The authors conducted a cohort study. This study was
conducted in two ICUs in Lyon University Hospital. The study
included 166 SS patients and 44 healthy volunteers. PAXgene
blood samples were obtained regularly in the course of the
syndrome for S100A9 gene expression analysis using qRT-PCR.
Results The overall mortality was 38% and the mean SAPS II on
shock onset was 52. Thirty-seven patients (23%) experienced at
least one HAI after septic shock. We found that S100A9 mRNA
levels at days 1 to 3 after the onset of shock were significantly
higher in SS patients compared with healthy volunteers (median:
1,460 vs. 16,620; P  <0.0001) but not significantly different in
nonsurviving versus surviving patients (median: 18,070 vs. 16,310;
P = 0.1278). In contrast, systemic S100A9 mRNA levels
measured at days 7 to 10 were significantly higher in the group of
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patients that were going to develop HAI compared with patients
that were not (median: 10,140 vs. 7,160; P = 0.009). Multivariate
analysis showed that the S100A9 mRNA level at days 7 to 10 after
the onset of septic shock significantly increases the probability of
HAI with odd ratios of 1.12 per unit (P = 0.0054).
Conclusions  Our results showed that S100A9 mRNA is
overexpressed in blood from SS. We showed that its persistent
overexpression over time is associated with the occurrence of
secondary HAI. This biomarker may be of major interest in identi-
fying patients at increased HAI risk who could benefit from either
targeted therapy aimed at restoring immune functions (in case of
associated immunosuppression) or reinforced antibiotherapy and
measures against cross-transmission.
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